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Objectives. People suffering from mental health conditions, often do not seek 
professional help. One of the reasons for this is that they do not consider 
talking-therapies sufficiently effective. It has been shown that among physical 
health conditions the rate at which people recover by themselves from a 
condition, as compared to those who do not (i.e. baseline-risk), unduly 
influences how effective people judge respective treatments. Treatments for 
conditions from which many people recover by themselves are considered as 
more effective than they actually are, as people credit the treatments for those 
that have recovered by themselves; the reverse is true for conditions from 
which many people do not recover by themselves. People may judge talking-
therapy on the basis of the baseline-risk, to the detriment of the actual 
treatment effect of talking-therapy, conceptualised as the absolute or relative 
reduction of risk. 
Design. A mixed factorial within-between subjects experiment. 
Participants. A general population sample (N=202), in which 75.8% of 
participants had symptoms of depression and anxiety indicating a mental 
health condition. 
Methods. Participants took part in a web-based experiment during which they 
were shown six vignettes about common mental health conditions and the 
effect of talking-therapy on these compared to no treatment. The six vignettes 
varied in the baseline-risk (high vs. low), the absolute risk reduction (high vs. 
low), and the relative risk reduction (high vs. low). The dependent variable was 
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the perceived effectiveness of talking-therapy, measured on a visual analogue 
scale from 0 (ineffective) to 100 (extremely effective). Analysis of covariance 
was conducted to control for potential confounding variables, including 
numeracy and mood. 
Results. Talking-therapies were judged on the basis of the baseline-risk of the 
condition. A higher baseline-risk was associated with a lower perceived 
effectiveness. This impact of the baseline-risk was not moderated by numeracy 
or mood. Talking-therapies were also judged on the basis of the absolute risk 
reduction but not by the relative risk reduction. There was some evidence that 
those with lower numeracy were less sensitive to differences in the treatment 
effect, that is, their judgments of effectiveness decreased less with a 
decreasing treatment effect. 
Conclusion. The evidence suggests that the effectiveness of talking-therapy is 
influenced by the baseline-risk of common mental health conditions. To 
address people’s judgement that talking-therapy is insufficiently effective may 
require considering the negative impact of the high baseline-risk inherent to 
common mental health conditions. In turn, this may increase uptake of talking-













1. Introduction  
Only a quarter of people with a mental health condition are in treatment (Mental 
Health Policy Group, 2012). One reason for this is that many people suffering 
from mental health conditions, even if severe, do not seek professional help 
(Oliver et al, 2005). There are several reasons for the low rates of help-seeking 
for mental health conditions among adults in the general population, including 
the perception that treatment will not help (Meltzer, 2000; Stecker, Fortney, 
Hamilton, Sherbourne, & Ajzen, 2010).  
Research into decision making about treatments for physical health conditions 
has demonstrated that a treatment is less likely to be perceived as helping 
when the natural recovery rate for the condition in the absence of treatment is 
low (Vogt, Mason, & Marteau, 2012). In other words, a treatment for a physical 
health condition from which few people would recover by themselves, is unduly 
judged as less effective. The inverse of the natural recovery rate of a condition 
or the proportion of those who do not get better by themselves is often referred 
to as the baseline-risk (B_RISK).  
Many people with common mental health conditions (CMHCs) do not get better 
by themselves (i.e. in the absence of treatment) (e.g. Bisson & Andrew, 2007; 
Hunot, Churchill, Teixeira, & Silva de Lima, 2007). For example, 89% of people 
with Post Traumatic Stress Disorder (PTSD; Bisson & Andrew, 2007), 86% with 
Generalised Anxiety Disorder (GAD; Hunot et al., 2007), 70% of people with 
depression (Layard, Clark, Knapp, & Mayraz, 2007), 95% of people with phobia 
(Layard et al., 2007), and 95% of people with obsessive-compulsive disorder 
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(OCD; Layard et al., 2007) do not get better by themselves. Thus, if 
perceptions of treatments for mental health conditions are judged on the basis 
of the natural recovery rate in the absence of treatment, they are likely to be 
judged as less effective than they actually are. In turn, this may contribute to 
the low rates of seeking professional help. Information aimed at increasing 
help-seeking could then be strengthened by taking into account the impact of 
those that do not get better in the absence of treatment, the B_RISK of 
CMHCs.  
The current research aims to address the question of whether perceptions of 
treatments for mental health conditions are judged on the basis of the B_RISK. 
1.1. The human and financial cost of mental health problems 
In the UK about 16% of adults are experiencing a CMHC (McManus, 2009; 
Mental Health Policy Group, 2012). CMHCs are mental health conditions that 
cause marked emotional distress and interfere with daily function, but do not 
usually affect insight or cognition. The term CMHC is used throughout this 
thesis as is it used by the NHS in online information (NHS Choices, 2014). 
Other terms, such as Common Mental Health Problems or Disorders, are used 
interchangeably and describe the same difficulties (NICE, 2011a). CMHCs 
comprise different types of mood conditions. Research suggests that more than 
half of people with a CMHC, have a mixed anxiety and depressive disorder, 
other common ones are depression, obsessive compulsive disorder (OCD), 
generalised anxiety disorder (GAD), post-traumatic stress disorder (PTSD), 
panic disorders, social anxiety disorder, and phobias (McManus, 2009). 
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One way of assessing the impact of CMHCs is by judging the disability that the 
conditions place upon the individual. The World Health Organisation (WHO) 
measures this using disability-adjusted life years (DALYs) (WHO, 2014). This 
time-based measure combines years of life lost due to premature mortality and 
years of life lost due to time lived in states of less than full health. It allows 
comparison of disability across the spectrum of diseases, injuries, and risk 
factors, such as smoking. The WHO reports that on its own, depression places 
a huge burden on the individual (Mathers, Fat, & Boerma, 2008). In terms of 
DALYs, it ranks third place world-wide, eighth place in low-income countries, 
but first place in middle- and high-income countries. Only lower-respiratory 
infections and diarrhoeal diseases have a larger burden of disease world-wide. 
Another way of looking at the impact of CMHCs is to look at suffering, as 
measured by quality of life. In other words, how satisfying an individual 
perceives his/her life. Layard and colleagues show that poor mental health, 
measured six years previously, contributes more to current quality of life than a 
person’s current physical health or household income (Mental Health Policy 
Group, 2012).  
There is also a huge economic cost for society attached to CMHCs. 
Depression and anxiety make it much more difficult to work, and even those 
who are working have high rates of sickness absence leading to a large 
financial burden (Layard, 2005). In the Layard report, CMHCs are calculated to 
lead to annual losses of output to the size of £17bn (€24bn, $30bn), or 1.5% of 
UK gross domestic product. 
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1.2. The benefit of talking-therapy 
A solution to counter the impact of CMHCs is available in form of treatment. 
Since the 1950s, psychoactive medications are used to help with mental health 
conditions (Layard, 2012). Since the 1970s, psychological or talking-therapies 
have become more common, the most studied of which is cognitive behaviour 
therapy (CBT) (Layard, 2012). Both varieties of treatment have been tested in 
hundreds of trials and the results analysed and summarised in several 
Cochrane and National Institute for Health and Clinical Excellence (NICE) 
reviews (Hunot et al., 2007; NICE, 2009, 2011b). Psychoactive medication and 
talking-therapy, including CBT and some other forms, such as Interpersonal 
Psychotherapy, are found to be effective and provide substantial improvements 
or cure for many patients. As a result, the NICE Guidelines recommend that 
both medication and talking-therapy should be available as options for treating 
CMHCs (NICE, 2009, 2011b). While the evidence suggests that both 
medication and talking-therapy have similar recovery rates, the effect of talking-
therapy appears to be more long-lasting (Layard et al., 2007; Spielmans, 
Berman, & Usitalo, 2011).  
Research has suggested that, not only is talking-therapy effective, it is also 
cost-effective. In terms of Quality Adjusted Life Years (QALYs), talking-therapy 
compares favourably to the recommended maximum cost of treatment set by 
NICE at £30,000. Talking-therapy for CMHCs also compares favourably to 
many common treatments for physical illnesses. The cost per additional 
QUALY of CBT for depression is £6,700; by comparison, statins for cardio-
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vascular disease can cost £14,000 and topirimate for epilepsy costs £900 
(Mental Health Policy Group, 2012). 
The costs for treating CMHCs are thought to be more than recovered by 
savings made to the Department of Work and Pensions and the Her Majesty's 
Revenue and Customs (HMRC) in reduced benefits and additional taxes as 
more people work (Mental Health Policy Group, 2012). Large savings are also 
likely to be made directly within the NHS because of reduced physical health-
care costs. Evidence from a meta-analysis shows that physical health-care 
costs for patients receiving talking-therapy for CMHCs were lower compared to 
those not receiving such therapy (Chiles, Lambert, & Hatch, 1999). The lower 
costs were such that they more than covered the costs of the additional talking-
therapy, in essence reducing the total health-care-costs.  
1.3. The low uptake of talking-therapy 
Despite the existence and availability of effective treatments for CMHCs, 
uptake is low. Internationally, many people with CMHCs are not being treated 
(Alonso et al., 2007).  The situation is similar in the UK, where only a quarter 
(24%) of people with a CMHC are in receipt of treatment (McManus, 2009). 
Most individuals in the UK receive some form of medication, with 14% of adults 
with such conditions taking psychoactive medication. Only 5% receive talking-
therapy and 5% receive both, medication and talking-therapy.  
In response to this concern, and the economic drive to treat CMHCs, Improving 
Access to Psychological Therapies (IAPT) was launched in 2008 following a 
report by Layard (Mental Health Policy Group, 2006) with the ambition for 
psychological services to be more available. The aim of IAPT was providing 
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evidence based talking-therapy for anxiety and depression to 15% of those 
suffering from these conditions by 2014.  
1.4. Attempts to increase uptake 
Despite the enormity of the problem, a recent review of interventions to 
increase help-seeking for CMHCs identified only six peer-reviewed 
interventions of good quality on the topic (e.g. randomised) (Gulliver, Griffiths, 
Christensen, & Brewer, 2012). The interventions that were reviewed targeted 
factors such as (i) knowledge about mental health conditions to help recognise, 
manage, or prevent them, (ii) beliefs aimed at reducing stigma, or (iii) provided 
information about where to find and how to access providers. Whereas most 
interventions achieved changes in knowledge or beliefs consistent with seeking 
help, only one of three interventions that measured help-seeking increased 
behaviour. The review concluded that more work is needed to develop 
interventions that change help-seeking behaviour. 
As described, to increase uptake of talking-therapies in the UK, the nationwide 
IAPT service was introduced (Layard, 2005). It has had an impact on those 
seeking help, but cuts are now seen to the IAPT budgets in a number of 
primary care trusts, warranting some concern about the future impact (Mental 
Health Policy Group, 2012).  
1.5. What explains the low uptake 
The use of mental health treatment sits within the realm of help-seeking 
behaviour. In the health context, help-seeking is used to describe an adaptive 
form of coping with illness including the seeking of help from professionals 
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(Mechanic, 1962). Help-seeking developed in the literature on illness 
behaviour, which described the way people monitor their bodies, define and 
interpret their symptoms, take preventive or remedial action, or utilize the 
health care system (Mechanic, 1962).  As far back as in the 1970s, only 10% of 
people consulted professionals for significant health symptoms they 
experienced (Tuckett, 1976).  
The reasons put forward for these low rates of help-seeking in the health-
context in the 1970s included a change in the nature of health conditions. 
Chronic illness and mental health conditions became major health concerns in 
the 20th century, replacing acute conditions as the main service provided by the 
health care system. Such conditions can be difficult to identify and interpret as 
something that is appropriate for professional health care. It has therefore been 
argued that the process of help-seeking has become more about the 
individual’s decision making, than about the condition’s acute impact on 
functioning (Rosenstock & Kirscht, 1979). 
1.5.1. Psychological models 
Four levels have been described that can help understand health care 
utilisation: the individual, health care groups or teams, organisations providing 
health care, and the larger health care system in which individual organizations 
are embedded (Ferlie & Shortell, 2001). These levels were already discussed 
in the context of help-seeking behaviour in 1976: including investigations of the 
individual’s disposition to use certain kinds of services, patients’ interpretations 
of their symptoms, and research on the effect of the organization and the issue 
of accessibility (Lewis, Fein, & Mechanic, 1976). Different levels of explanation 
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require different types of theory. For example, psychological theories will be 
more relevant for understanding individuals and teams, and theories of 
organisational change will be more relevant to hospitals or trusts (Walker et al., 
2003).  
Despite the wide range of factors that may influence the use of professional 
health care, even the least individually based theories which consider that the 
use of professional health care is determined by organisational factors assume 
that change is channelled through the actions of individuals (Iles & Sutherland, 
2001). This is one reason why psychological theories have been influential in 
explaining health care behaviours (Walker et al., 2003).  
Another is that they are thought to be more amenable to change. It is widely 
accepted that it is the attribution of events rather than the events themselves 
that motivate behaviour (Bandura, 1986; Beck, Rush, Shaw, & Emery, 1979). 
For example, research on health behaviours showed how the beliefs about the 
causes and controllability of their illness impacted on choice of treatment 
(Bradley et al., 1987). The relative importance of cognitive factors in 
determining health behaviours has led to the development of a large number of 
theories of health behaviour, which collectively are often referred to as social 
cognition models. Consistent with the hypothesis that it is an individual’s 
attribution of events rather than the events themselves, these models postulate 
that cognitions about the behaviour and the illness meditate the impact of other 
factors (e.g. sociodemographic, health status, personality traits, genes) on the 
behaviour  (Conner & Norman, 1996).  
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Evidence from meta-analyses supports the so called social cognition models. 
They show that they account for a substantial proportion of the variance in 
behaviour, leaving little or no variance that is explained by other factors, apart 
from past behaviour, which often accounts for unique variance (Floyd, Prentice-
Dunn, & Rogers, 2000; Godin & Kok, 1996; Milne, Sheeran, & Orbell, 2000). 
Two models will be explored in more detail to illustrate how the low rate of 
seeking help for CMHCs may be explained: the Health Belief Model (HBM) and 
the Theory of Planned Behaviour (TPB). The HBM is described because it was 
designed specifically to investigate uptake of health care programs and 
remains one of the most commonly used theories in health education and 
health promotion (Glanz, Rimer, & Lewis, 2002; Painter, Borba, Hynes, Mays, 
& Glanz, 2008), including mental health care use (Henshaw & Freedman-Doan, 
2009). The TPB was selected because over the last three decades it has been 
considered to be the dominant theoretical approach to guide research on 
health-related behaviour (Sniehotta, Presseau, & Araújo-Soares, 2014).  
Health belief model 
One of the first social cognition models that looked at individual decision 
making with regards to health behaviours was the HBM (Becker, Maiman, 
Kirscht, Haefner, & Drachman, 1977; Rosenstock, Strecher, & Becker, 1994). 
This model was initially proposed by health researchers involved in promoting 
health care programs and it attempts to understand the beliefs that make a 
behaviour more or less attractive. According to the HBM, the likelihood that 
individuals will take action, i.e. perform some health, illness or sick-role 
behaviour, is dependent on the outcome of two assessments they make. One 
of the assessments pertains to the threat of a health problem, and the other 
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weighs the pros and cons of taking action (also referred to as the behavioural 
evaluation). The factors included in the evaluation of threat are: 
 ‘Perceived severity of the health problem’: People consider how severe 
the organic, financial, psychological, and social consequences are likely to be if 
they develop the problem or leave it untreated. The more serious they believe 
the effects will be, the more likely they are to take action. For example, the 
degree to which people believe that OCD has a severe impact on their ability to 
function normally in everyday life, should influence who likely they are to seek 
professional help. 
 ‘Perceived susceptibility to the health problem’: Individuals evaluate the 
likelihood of developing/having the problem. The more vulnerable they perceive 
themselves to be, the more likely they will take action. For example, accepting 
that one has OCD, should make it more likely to seek professional help. 
The factors that are included in the behavioural evaluation are: 
 ‘Perceived benefits’: Individuals also evaluate the potential advantages 
of initiating a particular health behaviour or stopping some harmful health 
behaviour. The greater the benefits are perceived the more likely an individual 
will engage in the health behaviour.  For instance, an individual who is deciding 
to start seeing a therapist might think ‘going to have therapy will help me with 
my OCD’. 
 ‘Perceived barriers’: People often assess the costs of altering a 
particular behaviour. The greater the costs are perceived to be, the less likely 
an individual will engage in the behaviour. For instance, an individual who has 
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decided to go to a therapist, might realise that going to see a therapist will take 
a lot of time, and thus decide against it. 
 
 
Note: Adapted from Rosenstock et al., 1994 
 
In addition to these four factors, three others are believed to modify people’s 
decision to seek help. These factors are socio-demographic variables, socio-
psychological variables (e.g. personality traits, social pressure), which are 
regarded to influence the evaluation of threat and the behavioural evaluation,  
and cues to action (i.e. people who are reminded about a potential health 
problem are more likely to act). Thus, for example, individuals whose close 
siblings have developed OCD are likely to perceive a greater threat of illness 
than individuals whose siblings are in good health. Similarly, it might be a 
trigger to seek help if the sibling’s mental health declines. 
The HBM has been applied to a broad range of health behaviours and 
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Figure 1.1: Conceptualisation of the Health Belief Model 
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Three main areas of behaviours have been identified, including (i) preventive 
health behaviours (e.g. stopping smoking), (ii) compliance behaviours (e.g. 
following medical regimes after professional diagnoses, and (iii) clinic use, that 
is visiting health professionals for a variety of reasons. A meta-analysis of 234 
studies looked at the predictive ability of the HBM components (Harrison et al., 
1992). The results showed that each of the four components, susceptibility, 
severity, benefits and barriers were predictive of behaviour, with each 
component accounting for approximately 4% of variance in behaviour across 
studies. A more recent meta-analysis that assessed whether the components 
could longitudinally predict behaviour found that benefits and barriers were the 
strongest predictors, predicting 7% and 9%, respectively, in behaviour 
(Carpenter, 2010).  
Theory of Planed Behaviour  
Another model is the TPB which originated in the field of social psychology 
(Ajzen, 1991). It was originally developed from early work on the psychological 
processes demonstrating that attitudes might cause behaviour and the failure 
to predict behaviour from knowledge (Fishbein, 1963). The work led to a new 
variable between attitudes and behaviour, behavioural intention, which showed 
to be a powerful explanatory factor (Ajzen & Fishbein, 2005). The model 
includes four main components: 
 ‘Behavioural intention’: Behavioural intention is defined as a conscious 
plan to perform a behaviour.  
 ‘Perceived behavioural control’: Perceived behavioural control refers to 
people's perceptions of their ability to perform a given behaviour. 
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 ‘Attitude’: Attitude towards a behaviour can be defined as an overall 
positive or negative evaluation of engaging in a behaviour. 
 ‘Subjective norm’: Subjective norm can be described as an individual’s 
perception of social normative pressures, or relevant others’ beliefs that he or 
she should or should not perform a behaviour. 
 
 
Note: Adapted from Ajzen, 1991 
The TPB posits that an individual’s intention to engage in a behaviour, and the 
degree of perceived behavioural control over performing the behaviour are the 
proximal determinants of behaviour (Ajzen, 1991). An individual's intention to 
engage in a behaviour is determined by three factors: the attitude towards the 
behaviour, subjective norm and perceived behavioural control over it. The 
attitude towards a behaviour is proposed to be determined by the combination 
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Figure 1.2: Conceptualisation of the Theory of Planned Behaviour 
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symptoms, it will be expensive) and evaluations of those consequences (e.g. 
this is desirable vs. undesirable). The subjective norm is based on the 
combination of the perceptions of the views of other individuals about the 
behaviour (e.g. my friend would approve of seeking-help), and the strength of 
the individual's desire to gain approval of these individuals (e.g. it is important 
to me what my friend thinks). Perceived behavioural control is determined by 
the combination of beliefs about the perceived likelihood of potential barriers 
and facilitators to performing the behaviour (e.g. there is a long waiting time, 
the service is far away) and the perceived power of these factors to inhibit or 
facilitate the behaviour. It is by measuring these underlying beliefs that the TPB 
becomes sensitive to diverse issues such as accessibility of services, patient 
preferences, or stigma. 
Several meta-analyses have reviewed this model (Armitage & Conner, 2001; 
Godin & Kok, 1996). Godin and Kok (1996) focussed on health-related 
behaviours and found an average correlation of r = .46 between attitude and 
intention, r = .34 between subjective norm and intention, and r = .46 between 
perceived behavioural control and intention. Attitude, social norm, and 
perceived behavioural control together explained 41% of variance in intention, 
whilst intention and perceived behavioural control explained 34% of variance in 
behaviour. 
1.5.2. Review of predictors of uptake 
Psychological models have been popular in accounting for the low uptake of 
treatments for CMHCs. Models that have been used to account for decisions to 
engage in treatment for mental health conditions, include the HBM (e.g. 
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Connelly, 1984; Kelly, Mamon, & Scott, 1987; Pan & Tantam, 1989), the TPB 
(e.g. Hyland, Boduszek, Shevlin, & Adamson, 2012; J. P. Smith, Tran, & 
Thompson, 2008; Stecker et al., 2010; Westerhof, Maessen, de Bruijn, & 
Smets, 2008), the service utilization framework (e.g. Aday & Andersen, 1974; 
Andrews, Issakidis, & Carter, 2001), the stages of help-seeking model 
(Rickwood, Deane, Wilson, & Ciarrochi, 2005), and the network episode model 
(Pescosolido, Gardner, & Lubell, 1998; Pescosolido, 1992). 
A systematic review looking at the use of theoretical frameworks in studying 
help-seeking behaviour for CMHCs found that the majority of studies applied 
no framework (i.e. 81%) (Rickwood & Thomas, 2012) and that the most 
common framework was the TPB (Ajzen, 1991). Most models consider factors 
such as motivation, attitude, perceived threat, and beliefs about enabling 
resources and beliefs about the benefits of therapy as predictors of help-
seeking behaviour. Indeed, a review of the different models concludes that 
there is substantial overlap (Fishbein et al., 2001). 
Another review investigated the most frequently reported perceived barriers 
and facilitators to help-seeking behaviour for CMHCs (Gulliver, Griffiths, & 
Christensen, 2010). In the seven studies that the review included, the most 
frequently mentioned barriers were being uncomfortable talking about personal 
things, a belief that self-reliance was preferable to seeking help, the belief that 
support would not be beneficial, fear of stigma, and that it was too expensive. 
For example, in one study conducted among over 1000 adolescents, 55% of 
respondents believed that no person or service could help them with their 
CMHC and that 53% believed that their problem was too personal to tell 
anyone (Dubow, Lovko Jr., & Kausch, 1990). 
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While the frequency with which a particular belief is held in the population of 
people with and without a CMHC is helpful at providing an overview of the 
negative and positive views held, this information alone does not indicate the 
extent to which a respective belief is important for people’s decisions to seek 
help. That is, although some beliefs may be held very strongly, they may not 
actually determine a persons’ motivation to seek help or seeking help itself. To 
establish the relative importance of beliefs with regards to help seeking 
behaviour it is necessary to consider the association that beliefs have with 
seeking help for a CMHC, or a proxy thereof (i.e. intention to seek help) if 
actual behaviour was not measured. Unfortunately, no review could be 
identified that investigated the predictors of help-seeking behaviour in the 
context of CMHCs.  
The literature shows that several studies could predict the intention to seek-
help for CMHCs (Hyland, Boduszek, et al., 2012; Hyland, McLaughlin, 
Boduszek, & Prentice, 2012; Mackenzie, Gekoski, & Knox, 2006; Mackenzie, 
Knox, Gekoski, & Macaulay, 2004; Mills, 2010; Skogstad, Deane, & Spicer, 
2006; J. P. Smith et al., 2008; Stecker et al., 2010; Vogel, Wester, Wei, & 
Boysen, 2005; Westerhof et al., 2008). In studies that used multivariate 
approaches, the variance accounted for in intention ranged between 30% to 
92%. This is broadly consistent with the findings reported for the TPB in 
predicting behavioural intention across other health behaviours. 
While some studies only used attitude to predict intention (Mackenzie et al., 
2006, 2004; J. P. Smith et al., 2008; Westerhof et al., 2008), others included 
other factors from the TPB, by also measuring and evaluating the explanatory 
capacities of social norm and perceived behavioural control (Hyland, 
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Boduszek, et al., 2012; Hyland, McLaughlin, et al., 2012; Mills, 2010; Skogstad 
et al., 2006; Stecker et al., 2010; Vogel et al., 2005). When comparing the 
different factors, attitude emerged as the strongest predictor of intention in 
three studies (Mills, 2010; Skogstad et al., 2006; Vogel et al., 2005), followed 
by social norm in two studies (Hyland, Boduszek, et al., 2012; Skogstad et al., 
2006), and perceived behavioural control in one study (Hyland, McLaughlin, et 
al., 2012). 
Some studies have also looked more closely at the importance of individual 
beliefs, such as those proposed to underlie the attitude or social norm. For 
example, one study examined which beliefs are most predictive of attitude 
(Vogel et al., 2005). It found that attitude was most predicted by beliefs about 
treatment effectiveness, as compared to stigma, treatment fear, and fear of 
disclosure (Vogel et al., 2005). Other studies examined the extent to which 
beliefs directly predict intention (Mackenzie et al., 2006, 2004; Stecker et al., 
2010; Westerhof et al., 2008). In one of these, beliefs about treatment 
effectiveness were the most predictive of intention to seek help (Stecker et al., 
2010). The others looked at the predictive ability of clusters of beliefs, 
described as psychological openness (“the extent to which individuals are open 
to acknowledging psychological problems and to the possibility of seeking 
professional help for them” (Mackenzie et al., 2004: p 2420), help-seeking 
propensity (i.e. “the extent to which individuals believe they are willing and able 
to seek professional psychological help” (Mackenzie et al., 2004: p 2420), and 
indifference to stigma. Two found help-seeking propensity (Mackenzie et al., 
2006, 2004) and one psychological openness (Westerhof et al., 2008) most 
predictive of the intention to seek help. Unfortunately, none of these latter three 
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studies measured beliefs about treatment effectiveness. A narrative review 
comparing the relative importance of stigma versus the belief that seeking help 
is beneficial concluded that beliefs about treatment effectiveness are at the 
core of the intention to seek help for CMHCs (Schomerus & Angermeyer, 
2008).  
Only two studies were identified that predicted actual behaviour (Stecker et al., 
2010; Vogel et al., 2005). These used a prospective design, that is, they 
assessed the predictors at a time prior to measuring the dependent variable. 
Such a design strengthens the assumptions about the causal relations implied 
in many cross-sectional studies. In one of these two studies, intention 
explained 29% of the variance in seeking help for CMHCs and furthermore 
showed that beliefs about treatment effectiveness were associated with 
seeking help, when other beliefs were not (Stecker et al., 2010). In the other, 
beliefs about the effectiveness and having a distressing experience predicted 
seeking help, while controlling for gender, risk of treatment, and comfort of self-
disclosure, all of which had no impact on help-seeking behaviour (Vogel et al., 
2005). 
The literature on the predictors of help-seeking for CMHCs revealed some 
weaknesses. For example, few studies predicted actual behaviour and most 
investigated intention. Many studies asserting to use specific theoretical 
frameworks, such as the TPB, did not follow the theory’s framework of how to 
measure the constructs (Mackenzie et al., 2006, 2004; Skogstad et al., 2006; 
Vogel et al., 2005; Westerhof et al., 2008). For example, some created clusters 
of beliefs that appear to overlap with intention (e.g. help-seeking propensity; 
Mackenzie et al., 2006, 2004; Westerhof et al., 2008). Also, some studies were 
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not specific to talking-therapy, but described treatment for CMHCs as a 
combination of talking-therapy and medication, or as seeking out a mental 
health professional (Mackenzie et al., 2006; Skogstad et al., 2006; Stecker et 
al., 2010). However, others were specific to talking-therapy (e.g. Hyland, 
Boduszek, et al., 2012; Hyland, McLaughlin, et al., 2012; Mackenzie et al., 
2004; Vogel et al., 2005; Westerhof et al., 2008).  
In summary, factors postulated by social cognition models, appear to be a valid 
and useful framework to help understand the low rates of help-seeking for 
CMHCs. These factors, account for a substantial amount of variance in 
intention and behaviour. Bearing in mind the small number of studies, the 
attitude, more so than the subjective norm or the perceived behavioural control, 
predicted help-seeking. A key belief driving this relationship seemed to be 
beliefs about the effectiveness of the treatment at reducing symptoms. Public 
or private acceptability of seeking-help, stigma, or accessibility were other, 
albeit seemingly less important predictors. The findings are consistent with 
Layard’s analysis of the UK (Layard, 2013). While Layard did not conduct any 
primary research and the sources for his conclusions are not referenced, he 
postulated that people not realising that treatment is effective, is one of three 
factors that account for low treatment use. The other two factors postulated by 
Layard are: people and their relations are ashamed to admit there is a problem, 
and that facilities are not available.  
1.6. The neglected predictor: beliefs about the effectiveness 
The analysis of the existing literature on the predictors of help-seeking 
behaviours thus suggests that low use of talking-therapies for CMHCs is 
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associated with beliefs that treatment is ineffective, normative beliefs related to 
stigma, and the inaccessibility of services. It would follow then that an 
intervention to increase uptake should target such issues. 
In the UK, IAPT focussed on one of these factors, namely, the accessibility of 
talking-therapies. However, none of the interventions in the review of 
interventions aimed at increasing help-seeking for CMHCs targeted beliefs 
about the effectiveness of treatment (Gulliver et al., 2012). This is surprising 
given that the evidence suggested that this is among the strongest and most 
consistent individual predictors of help-seeking behaviour (Stecker et al., 2010; 
Vogel et al., 2005). Potentially, this is a result of the complexity of how beliefs 
that treatment is not effective might be addressed. 
Ultimately, even in the UK, addressing low rates of help-seeking by increasing 
only the accessibility will be limited to helping people with CMHCs whose main 
barrier is being unable to access a service. Increasing accessibility alone is 
unlikely to entice those who do not believe that talking-therapy is effective or 
those who avoid treatment for fear of stigma. Policy and interventions are likely 
to be more efficient if they addressed all factors underlying low rates of help-
seeking. 
That beliefs about the effectiveness are a key determinant of treatment for 
CMHCs is not unusual. Beliefs about the effectiveness have demonstrated to 
predict treatment use in a variety of contexts, for example stop smoking 
treatment or asthma medication (Floyd et al., 2000; Hammond, McDonald, 
Fong, & Borland, 2004; Horne & Weinman, 1998; Weinstein et al., 2007). 
Unsurprisingly, a large amount of resources is invested in determining how 
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best to communicate treatment effectiveness of medical intervention 
(Gigerenzer, Gaissmaier, Kurz-Milcke, Schwartz, & Woloshin, 2007). 
1.7. Making sense of treatment effectiveness  
Making sense of treatment effectiveness is not straightforward. Why is it that 
people do not judge treatment for CMHCs as sufficiently effective to use? 
Beyond the simple distinction about whether a treatment works or does not 
work, lies the question of how well a treatment works. To answer this more 
subtle question a number of different measures are used to describe, 
communicate, and understand the extent of a treatment’s effectiveness. 
Common measures include the absolute risk reduction (ARR), the number 
needed to treat (NNT), and the relative risk reduction (RRR).   
The ARR is the absolute reduction in rates of adverse outcomes between the 
therapeutic and the control group. For example, talking-therapy reduces 
generalised anxiety disorder (GAD) for 32 people in every 100 treated (Hunot 
et al., 2007). The NNT is an alternative, mostly used among clinicians, and 
signifies the number of people that need to receive the treatment for one 
person to benefit from the treatment. For example, 3 people with GAD need to 
receive talking-therapy for one person to go into remission as a result of 
treatment (Hunot et al., 2007). It is the multiplicative inverse of the ARR. The 
RRR, is the proportional reduction of adverse outcomes in the control group. 
For example, talking therapy reduces GAD by 37% (Hunot et al., 2007). See 




Table 1.1: Measures of treatment effectiveness described on the basis of CBT for GAD 
 
1.8. Misleading interpretations of treatment effectiveness  
Correctly understanding treatment effectiveness is a complex task, even for 
those with medical training. This is reflected in the observation that the 
effectiveness of a treatment is perceived differently depending on how the 
information about its effectiveness is presented (Covey, 2007). For example, 
the RRR often looks more impressive than the ARR leading to more favourable 
but less stable judgements of effectiveness (Baron, 1997; Covey, 2007; Gyrd-
Hansen, Kristiansen, Nexøe, & Nielsen, 2002; Gyrd-Hansen et al., 2002). This 
is true particularly at low B_RISKs, at which the RRR looks particularly 
impressive (Sackett, Richardson, Rosenberg, & Haynes, 1997). The reason is 





Baseline-risk (B_RISK) Absolute risk of illness in the 
absence of treatment, (i.e. those 
who have not recovered by 
themselves). 
0.86 or 86% 
Risk in treatment group 
(RT) 
Absolute risk of illness in the 
treatment group (i.e. those who 
have not recovered despite 
treatment). 
0.54 or 54% 
Measure of treatment 
effectiveness 
  
Absolute Risk Reduction 
(ARR) 
ARR = B_RISK – RT 0.32 or 32% (i.e. 0.86 
- 0.54 = 0.32) 
Relative Risk Reduction 
(RRR) 
RRR = ARR / B_RISK  0.37 or 37% (i.e. 0.32 
/ 0.86 = 0.37) 
Number Needed to Treat 
(NNT) 
NNT = 1/ARR 3 (i.e. 1/0.32 = 3.125) 
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treating only a small additional number of people is a large reduction in relative 
terms (i.e. when two people are at risk, a treatment that helps one more person 
has a 50% RRR). It needs to be remembered that at the beginning of treatment 
it is not known who will recover naturally, meaning that all participants need to 
receive the treatment even if 98% would have recovered without it. If at all, it is 
recommended that the RRR should not be used without presenting the 
absolute risk in the control group (i.e. B_RISK) to avoid giving an unrealistic 
impression of the treatment effectiveness (Cook & Sackett, 1995; Gigerenzer, 
2003; Schwartz, Woloshin, Dvorin, & Welch, 2006). For the above reasons the 
ARR is generally preferred (Cook & Sackett, 1995; Gigerenzer, 2003; Schwartz 
et al., 2006). Understanding the effectiveness of treatments is best when 
information is presented with the B_RISK, in natural frequencies, with 
pictographs, and using an incremental risk format (e.g. ARR) to highlight how 
treatment changes risks from the pre-existing B_RISK (Gigerenzer et al., 
2007). The NNT is generally regarded as an appropriate alternative for health 
professionals (Gigerenzer et al., 2007). 
As the health-care service develops, patients are more commonly offered 
information when making a decision about whether or not to opt for treatment. 
For example, information about cancer treatments is often presented in terms 
of the ‘survival rates’, which refers to the proportion of people who are alive 
after a certain period of time following treatment (e.g. Cancer Research UK, 
2013; MayoClinic, 2013); the inverse of the risk remaining in the treatment 
group. Sophisticated decision tools have been developed to help patients make 
decisions about whether or not to opt for treatment given a predicted 
effectiveness (Michaelson, 2011; Wishart et al., 2010). Following guidelines on 
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how to best present information, these tools present the effectiveness using the 
B_RISK and the ARR with pictographs. For example, ‘Predict’ 
(www.predict.nhs.uk ) from the UK National Health Service, for adjuvant 
therapy following surgery for breast cancer, reports the number of women alive 
at 5 years with no adjuvant treatment following surgery, the extra number of 
women treated that are alive because of hormone therapy, and the overall 
survival rate with adjuvant treatment (Wishart et al., 2010). Similar tools are 
available for other medical conditions (e.g. J. McCormack, 2013).  
1.9. Impact of the B_RISK on perceptions of treatment 
effectiveness 
However, research suggests that even if treatments are presented following 
current best practice guidelines (Gigerenzer et al., 2007) heuristics may 
adverse affect decisions about whether treatments are effective (Vogt et al., 
2012). Heuristics can be described as thinking short cuts that humans employ 
to make decision making more efficient but which can lead to errors (Tversky & 
Kahneman, 1974). Specifically, evidence showed that presenting the B_RISK 
biases treatment perceptions (Vogt et al., 2012). This finding does not reflect a 
well know heuristic, the base-rate neglect, when individuals fail to account for 
the frequency of a characteristic in the population (Bar-Hillel, 1980). 
A normative argument would state that the effectiveness of treatments should 
be judged on nothing but the treatment’s effectiveness, the ability to reduce the 
risk of illness compared to no treatment. For physical health conditions, 
research demonstrated, however, that people consider treatments to be more 
effective for conditions in which most people get better by themselves (i.e. 
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conditions with low B_RISKs), regardless of actual treatment effectiveness 
(Vogt et al., 2012). In other words, people appear to look at the overall chance 
of a good outcome when they judge treatment effectiveness (i.e. in effect 
crediting treatments for good outcomes that result from people getting better by 
themselves). 
To illustrate, imagine there are two groups with 100 patients each. One group 
has a condition called Lowbaserisk and the other Highbaserisk. They are both 
anxiety disorders of similar severity. Of those with Lowbaserisk, 99% go into 
remission after treatment. By contrast, in those with Highbaserisk, 46% go into 
remission after treatment. But, treatment for Lowbaserisk and Highbaserisk 
helps the same number of people, namely 32 out of every 100 treated. The 
large difference in people who continue to suffer is therefore determined by the 
B_RISK, which is 33% in Lowbaserisk and 86% in Highbaserisk. In other 
words, people with Lowbaserisk have a much higher rate of getting better by 
themselves and for that reason most people are in remission after treatment. 
The research from physical health conditions, described in the preceding 
paragraph, showed that many people judge a treatment for a condition such as 
Lowbaserisk as more effective than that for Highbaserisk; even though each 
treatment helps 32 out of every 100 treated. 
Given that people appear to be influenced by the B_RISK when they judge 
treatments for physical health conditions, the B_RISK may also influence 
decisions about CMHCs. This is important because in CMHCs, such as 
generalised anxiety disorder (GAD), most patients (i.e. 86%) remain unwell 
without treatment (Hunot et al., 2007). This high B_RISK may reduce 
perceptions that psychological treatments for CMHCs are effective, despite 
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their substantial impact (i.e. talking-therapy helps 32% of people with GAD). In 
turn, this may lead to low help-seeking behaviour for CMHCs. This thesis will 
therefore examine the extent to which beliefs about the effectiveness of talking 
therapies for CMHCs are influenced by the B_RISK. 
1.9.1. Previous research on the B_RISK 
Previous studies have described the impact of the B_RISK on treatment and 
policy decisions. However, these either failed to exclude an alternative 
explanation, namely differences in treatment effect, or failed to distinguish 
between treatment effect and B_RISK (e.g. Fetherstonhaugh, Slovic, Johnson, 
& Friedrich, 1997; Friedrich et al., 1999; Gyrd-Hansen et al., 2002; V. K. Smith 
& Desvousges, 1987). The challenge in separating the impact of the B_RISK 
from the treatment effect on treatment and policy decisions is twofold: (i) 
treatment effects can be measured in different ways, such as the ARR or the 
RRR, and (ii) they cannot be varied independently, holding constant the 
B_RISK, an increase in one measure of treatment effect (e.g. ARR) is mirrored 
with an increase in the other measure of treatment effect (e.g. RRR).  
For example, one study asked participants to choose between two treatments 
of equal ARR. The treatments were ‘Treatment for illness X’ with a B_RISK of 
20/1000 and an ARR of 10/1000 and ‘Treatment for illness Y’ with a B_RISK of 
80/1000 and an ARR of 10/1000 (Gyrd-Hansen et al., 2002). The resulting 
RRR for ‘Treatment for illness X’ is 50%, whereas the RRR for ‘Treatment for 
illness Y’ is only 12.5%. However, the values of the RRR were not actually 
communicated to participants. The study found that despite the equal ARR, of 
those willing to choose between treatment X and treatment Y, 59% chose 
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treatment X whereas 41% opted for treatment Y. The findings were interpreted 
as “This result suggests that baseline risk information influences preferences, 
and that a majority of respondents prefer options that provide a higher RRR (p. 
73)”. While the researchers clearly acknowledge, both, the RRR and the 
B_RISK they do not distinguish between them, leaving their interpretation 
ambiguous about whether the preference for treatment X was caused by the 
lower B_RISK, the higher RRR, or both. Therefore, the study does not provide 
evidence that the B_RISK influences perceptions about treatments. 
In another study, participants were asked to compare the benefit of installing 
fresh water systems in one of two refugee camps (Fetherstonhaugh et al., 
1997). The camps were called Moga 1 and Fizi 1. The fresh water systems 
would save 1500 people from unclean water in each camp. The camps differed 
in that prior to the aid, 5% of the water in Moga 1 met current clean water 
standards and with the aid 50% of the standard would be met. In Fizi 1, prior to 
the aid, 50% of the water met current clean water standards and with the aid 
95% of the standard would be met. Participants were asked about which of the 
two programs provided more benefit. The findings showed that participants 
considered the aid program for Fizi 1 to be more beneficial. The findings were 
interpreted to reflect that the participants had a preference for programs in 
camps that only needed little extra help. The authors describe this 
phenomenon as the “diminished sensitivity in valuing lifesaving interventions 
against a backdrop of increasing numbers of lives at risk”, or in short, 
"psychological numbing"(Fetherstonhaugh et al., 1997, p. 283) or “drop in the 
bucket effect” (Fetherstonhaugh et al., 1997, p. 285). In this study, prior risk is 
the B_RISK, and is 95% in Moga 1 and 50% in Fizi 1. Both programs have an 
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ARR of 45%. However, the researchers do not consider that the RRR for Moga 
1 is 47% and the RRR for Fizi 1 is 90%. In other words, the preference for Fizi 
1 may have occurred because of the lower B_RISK or the higher RRR; the 
study therefore does not provide evidence that the B_RISK influences 
perceptions. 
Another study that pursued the “psychological numbing” effect investigated 
students’ willingness to support mandatory antilock brake requirements for new 
cars (Friedrich et al., 1999). In the study, participants in two conditions were 
either informed that the continued use of conventional braking system cost 
9000 or 41000 lives per year. In each condition, participants were informed that 
mandatory antilock brake requirements for new cars would save 150 lives per 
year. The results showed that participants were more in favour of mandatory 
antilock brake systems if conventional braking system cost 9000 lives per year. 
The results were interpreted as participants “value of life-saving interventions in 
proportional terms” (Friedrich et al., 1999, p. 296). The authors therefore 
suggest that the observed effect is the result of the impact of the RRR. In the 
article, the authors do not provide the RRRs, but these can be calculated as 
1.6% (i.e. 150/9000) and 0.4% (i.e. 150/41000). Their design and interpretation 
suggests that the authors do not separate between the B_RISK and the RRR. 
However, the results of the study can be interpreted as resulting from a 
preference for a lower B_RISK (i.e. 9000) over a higher B_RISK (i.e. 41000), a 
preference for a higher RRR (i.e. 1.6%) over a lower RRR (i.e. 0.4%), or both. 
The study therefore does not provide evidence that the B_RISK, or indeed the 
RRR, influences preferences because the factors are treated as if they were 
one and the same. 
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Yet another study conceptualised the “drop in the bucket” phenomenon as one 
in which people respond to relative differences (Baron, 1997). In doing so the 
study also failed to consider that the concepts B_RISK and RRR may have 
independent effects on decisions. The study asked participants how much they 
were willing to pay for an extra procedure to be included in their health 
insurance. Participants were presented with four vignettes: (i) 1000 die of this 
disease and the procedure will save 900 lives, (ii) 100 die of this disease and 
the procedure will save 90 lives, (iii) 10000 die of this disease and the 
procedure will save 900 lives, and (iv) 1000 die of this disease and the 
procedure will save 90 lives. These vignettes were then construed in a 2 (ARR: 
900 vs. 90) x 2 (RRR: 90% vs. 9%) factorial design. The findings showed that 
participants were willing to pay more for the procedures that saved 900 lives 
than those that saved 90, and that they were willing to pay more for procedures 
that reduced the risk by 90% than those that reduced risk by 9%. However, in 
the study it was not considered that, combined, the procedures that offered the 
high RRRs (i.e. 90%), also had lower B_RISKs (i.e. 100 and 1000) compared 
to the procedures that offered the low relative reduction (i.e. 9%), which had 
higher B_RISKs (i.e. 1000 and 10000). It is thus possible that the greater 
willingness to pay for procedures that reduced the risk by 90% was caused by 
the lower B_RISKS (i.e. 100 and 1000 vs. 1000 and 10000). The study 
therefore failed to control for the interconnectivity of the ARR, the RRR, and the 
B_RISKs.  
While the treatment effect and the B_RISK cannot be varied independently, 
their interconnectivity is non-parallel: an increase in the ARR increases the 
RRR more strongly at a lower B_RISK than at a higher B_RISK. This non-
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parallel interconnectivity can be exploited and was used to establish the 
independent impact of the B_RISK on how effective treatments for physical 
health conditions are perceived to be, while controlling for treatment effects as 
measured by the ARR and the RRR (Vogt et al., 2012). The current study will 
also exploit this non-parallel interconnectivity. 
1.10. Impact of the ARR and the RRR on perceptions of 
treatment effectiveness 
While it was established that the B_RISK had an independent impact on 
perceptions about treatment effectiveness (Vogt et al., 2012), previous studies 
were not designed to examine whether the ARR and/or the RRR also had an 
independent impact on treatment perceptions. The current study will therefore 
also examine whether the ARR and/or the RRR have an independent impact 




Decisions about the effectiveness of talking-therapy for CMHCs may also be 
influenced by the mood of the person making the decision. People often 
respond in coherence with their mood (de Vries, Holland, Corneille, Rondeel, & 
Witteman, 2012). This suggests that people with low mood may consider 
talking-therapy for CMHCs more negatively (i.e. less effective). However, 
people with low mood also pay more attention to the rules that determine 
utilitarian decisions and are less influenced by experience (de Vries et al., 
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2012). This suggests that while people with low mood may judge the 
effectiveness of talking-therapy as less effective, they may, at the same time be 
less influenced by the B_RISK. The effects of mood will be controlled for in the 
analyses to minimise a confounding effect.  
1.11.2. Numeracy 
The search for the optimal way of communicating treatment information is 
driven by the acknowledgement that medical information is often complex and 
that people can find it difficult to understand this information (Gigerenzer et al., 
2007). There is also an understanding that many people have poor numeracy 
skills, for example difficulties with a broad range of concepts, including 
fractions, proportions, and probability judgments (Reyna & Brainerd, 2007). A 
large body of evidence shows that poor numeracy skills predict poorer health 
outcome, less accurate perceptions of health risks, and a compromised ability 
to make medical decisions (Ancker, Senathirajah, Kukafka, & Starren, 2006; 
Brown et al., 2011; Galesic, Garcia-Retamero, & Gigerenzer, 2009; Reyna & 
Brainerd, 2007).  
Despite the general consensus that poor numeracy is associated with poorer 
medical decisions, previous research examining the B_RISK did not detect that 
numeracy moderated the impact of the B_RISK on the perceived effectiveness 
of treatments for physical conditions (Vogt et al., 2012). In other words, the 
B_RISK seemed to influence people’s perceptions of treatment effectiveness 
independent of whether they had lower or higher numeracy skills. However, 
numeracy is commonly seen to affect decision making, and therefore the 
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effects of numeracy will be controlled for in the analyses to minimise a 
confounding effect.  
1.12. Research aims and hypotheses 
The aim of this research is to examine the possible impact of the B_RISK and 
the actual treatment effectiveness, as measured by the ARR and the RRR, on 
perceptions of the effectiveness of talking-therapy. The importance of this 
question is based on the fact that perceptions of effectiveness are a key 
predictor of people using talking-therapy for CMHCs. The hypotheses are: 
Hypothesis 1:  Talking-therapies for conditions with higher B_RISKs are 
perceived as less effective. 
Hypothesis 2:  Talking therapies with higher ARRs are perceived as more 
   effective. 
Hypothesis 3:  Talking therapies with higher RRRs are perceived as more 












The analysis is designed as three 2 x 2 x 2 x 4 mixed within-between subjects 
factorial experiments: 
For Hypothesis 1, the within-subjects factors are the ARR (two levels: low vs. 
high) and the RRR (two levels: low vs. high), and the between subjects factors 
are mood (two levels: low vs. high) and numeracy (four levels: poor vs. fair vs. 
good vs. excellent).  
For Hypothesis 2, the within-subjects factors are the B_RISK (two levels: low 
vs. high) and the RRR (two levels: low vs. high), and the between subjects 
factors are mood (two levels: low vs. high) and numeracy (four levels: poor vs. 
fair vs. good vs. excellent). 
For Hypothesis 3, the within-subjects factors are the B_RISK (two levels: low 
vs. high) and the ARR (two levels: low vs. high), and the between subjects 
factors are mood (two levels: low vs. high) and numeracy (four levels: poor vs. 
fair vs. good vs. excellent). 
2.2. Procedure 
The study was conducted online. Participants were recruited through an 
advertisement (Appendix 1) placed via Google Ltd in the online advertisement 
spaces on the main Google websites as well as partnering organisations. 
Advertisements were directed to those above 18 years of age, limited to UK, 
and limited to tablets and computer access. Advertisement was displayed in 
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response to key words being used that related to CMHCs (Appendix 2). Those 
who clicked on the advertisement banner were directed to the study’s 
webpage. On the website participants were first provided with an information 
sheet describing the study. Participants could agree to participate by 
consenting to the study and were then directed to the questionnaire (Appendix 
4). In total, 1244 people clicked on the advertisement, of which 365 consented 
and arrived at the first page of the questionnaire between July 2013 and 
January 2014. Completion of items relating to the dependent variable (i.e. 
perceived effectiveness of talking-therapy) was not optional. Thus, if 
participants did not complete these items they could not progress to the next 
page. Of the 365 people consenting to the study, 210 completed the items 
relating to the dependent variable. Of the 210 people completing the 
questionnaire, 6 identified themselves as below 18 years of age and were 
excluded from the analysis. Two participants entered implausible data and 
were also excluded (more information about these two cases is provided in 
section 2.8). 
In the questionnaire, all participants were shown six vignettes depicting the 
effectiveness of talking-therapy for a CMHC. Each of the six vignettes was 
followed by a question asking participants about how effective they perceive 
talking-therapy was for the depicted CMHC (i.e. the dependent variable). All six 
vignettes were shown on one page, vertically, so that participants could scroll 
down the page to access all vignettes. Once participants had completed this 
part of the questionnaire, they were directed to the next section. There, 
participants provided information about their demographic details, their mood, 
experience with health problems, and numeracy. Finally, participants were 
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debriefed and offered accurate information about the effectiveness of talking-
therapies for CMHCs based on current evidence from the Cochrane library or 
the NICE. 
The study received ethical approval from the Royal Holloway Psychology 
Department Ethics Committee (Appendix 3). Pilot work demonstrated that 
completion of the entire study took approximately 10 minutes. Additional 
measures were collected but these are not part of this thesis (see Appendix 4). 
2.3. Participants 
Participants comprised a sample of the adult population (n=202). The mean 
age was 47.5 years with a standard deviation of 13.8 years. Age ranged from 
18 to 80 with good representation across all ages (Figure 2.1). Of the sample, 
26% were men, 93.5% were white. Of the participants, 55.3% had achieved at 
least A’ level or similar, or admission to university. At least two of the numeracy 
questions were correctly answered by 39.4% of participants. The majority, 
61.3%, had received treatment for a mental health problem in the past, and 
42.2% were currently receiving treatment for a mental health problem. For 156 
participants the location of where the questionnaire had been completed was 
collected automatically by the internet server. This automatically collected data 
suggested that participants came from all across the UK. Data from 105 
different cities was detected, with most participants coming from London (see 
Figure 2.2). See Table 2.1 for participants’ characteristics. 
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Figure 2.1: Distribution of participant ages 
 




Table 2.1 Participant characteristics (N = 202) 
Age (n=190) 
  Mean (Std. Deviation) 




  Male(n) 




  White (n) 
  Mixed (n) 
  Black or Black British (n) 
  Asian or Asian British (n) 







  No education completed 
  Primary (primary school) 
  Secondary 1 (compulsory education, GCSE, O level, or similar) 
  Secondary 2 (admission to university, A level or similar) 







  0 correct answers  
  1 correct answer  
  2 correct answers 





Previous treatment for mental health problem (n=199) 
  Yes (n) 
  No (n) 
61.11% (121) 
38.89% (77) 
Current treatment for mental health problem (n=199) 
  Yes (n) 




  Mean (Std. Deviation) 




  Mean (Std. Deviation) 




  Mean (Std. Deviation) 





2.4.1. Perceived effectiveness of treatment 
The perceived effectiveness of talking-therapy presented by a vignette was 
assessed with one item, displayed beneath each vignette. The item read: “How 
effective is talking-therapy for this condition compared to no treatment?” The 
item was measured, using a continuous visual analogue scale, response 
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options ranging from ‘ineffective’ (0) to ‘extremely effective’ (100). To respond, 
participants could drag a visual pointer between the two endpoints, indicating 
their judgement. Visual analogue scales are comparable in sensitivity and 
reproducibility to Likert scales (H. M. McCormack, Horne, & Sheather, 1988) 
although appear to be slightly superior (Grant et al., 1999). Visual analogue 
scales have also found to be successful at evaluating the effectiveness of 
treatments and found to be superior to category rating scales (Carling et al., 
2008). 
2.4.2. Mood 
As mood may be a confounding factor in participants’ responses (i.e. people 
who are experiencing symptoms of depression or anxiety may respond 
differently from those who are not) it was necessary to control for mood. Mood 
was measured using the Patient Health Questionnaire-4 (PHQ-4) (Kroenke, 
Spitzer, Williams, & Löwe, 2009). The PHQ-4 is an ultra-brief self-report 
questionnaire based on commonly used measures of depression and anxiety 
(PHQ-9, Kroenke, Spitzer, & Williams, 2001; GAD-7, Spitzer, Kroenke, 
Williams, & Lowe, 2006).  
The PHQ-4 consists of a 2-item depression scale (PHQ-2) (Kroenke, Spitzer, & 
Williams, 2003) and a 2-item anxiety scale (GAD-2) (Kroenke, Spitzer, 
Williams, Monahan, & Lowe, 2007). The PHQ-2 has been found to be a valid 
screening tool for major depression in adults and older adults (Kroenke et al., 
2003; Li, Friedman, Conwell, & Fiscella, 2007; Löwe, Kroenke, & Gräfe, 2005). 
In a review of ultrashort measures of anxiety the GAD-2 instrument performed 
best, and was the one measure that met two key criteria with good diagnostic 
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accuracy and feasibility (NICE, 2011a). It is recommended as an identification 
tool for anxiety disorders in primary care, in particular GAD, by NICE (NICE, 
2011a). The combined PHQ-4 has also been shown to be reliable and valid in 
a large general population sample (Löwe et al., 2010).  
Whereas the PHQ-2 consists of the two DSM-IV diagnostic core criteria for 
depressive disorders (American Psychiatric Association, 2000), the GAD-2 
consists of the two core criteria for GAD, which have also been shown to be 
effective screening items for panic, social anxiety, and PTSD (Kroenke et al., 
2007). Equivalent to the parent scales, the PHQ-4 begins with the stem 
question: “Over the last 2 weeks, how often have you been bothered by the 
following problems?”. The two PHQ-2 items are: “Little interest or pleasure in 
doing things” and “Feeling down, depressed, or hopeless”. The two GAD-2 
items are: “Feeling nervous, anxious or on edge” and “Not being able to stop or 
control worrying”. Response options are ‘not at all’, ‘several days’, ‘more than 
half the days’, and ‘nearly every day’, scored as 0, 1, 2, and 3, respectively.  
The four items were combined into a composite four-item scale. Therefore, the 
total score ranges from 0 to 12. For the PHQ-2 and the GAD-2, scale scores of 
≥3 are suggested as cut-off points between the normal range and probable 
cases of depression or anxiety, respectively (Kroenke et al., 2007, 2003; Löwe 
et al., 2010). For the PHQ-4 a score of ≥6 has been described as indicating the 
possible presence of a depressive or an anxiety disorder (Löwe et al., 2010). 
The PHQ-4 scores were then categorised into two groups, those scoring below 
the clinical cut-off (i.e. <6) and above cut-off (i.e. ≥ 6). Splitting the data in this 
way achieved a balance between making the variable useable and 




As stated, previous research has suggested that numeracy skills are related to 
medical decision making. In order to control for numeracy, it was measured 
using three standard items forming a global numeracy scale that is not specific 
to health numeracy (Schwartz, Woloshin, Black, & Welch, 1997). When 
compared to specific health numeracy measures, this 3-item scale was found 
to measure the same underlying global numeracy construct (Lipkus, Samsa, & 
Rimer, 2001).This non-health specific short measure is now common among 
studies investigating numeracy and the communication of medical risks (e.g. 
Estrada, Barnes, Collins, & Byrd, 1999; Galesic et al., 2009; Vogt et al., 2012). 
The three items were: (i) “Imagine that we flip a fair coin 1,000 times. What is 
your best guess about how many times the coin would come up heads in 1,000 
flips?”; (ii) “In the Big Cash Lottery, the chance of winning a £10 prize is 1%. 
What is your best guess about how many people would win a £10 prize if 1000 
people each buy a single ticket for Big Cash Lottery?”; (iii) “In the Bargain Cars 
Sweepstakes, the chance of winning a car is 1 in 1,000. What percent of tickets 
from Bargain Cars Sweepstakes win a car?”. Participants could score three 
points if they answered all three questions correctly. Responses were 
combined into a 4-point scale (i.e. 0 = poor numeracy, 1 = fair numeracy, 2 = 
good numeracy, 3 = excellent numeracy).  
2.4.4. Demographic information 
To provide information about the participants’ characteristics, demographic 
information was collected about age, gender, ethnicity, and education. These 




Standard procedures were used for measuring ethnicity in the UK following the 
2001 census presentation (Statistics, 2003). The item read: ‘What is your 
ethnic group?’. The response groups included: White, mixed, Asian or Asian 
British, Black or Black British, Chinese or other ethnic group. For the analysis 
the groups were collapsed into ‘white’ vs. ‘non-white’. 
Education 
 Education was measured using one item, “What is your highest level of 
education completed?” (Vogt et al., 2012). The response options included: No 
education completed, Primary (primary school), Secondary 1 (compulsory 
education, GCSE, O level, or similar), Secondary 2 (admission to university, A 
level or similar), Tertiary (university and other forms of education after the 
secondary level).  
Other mental health information 
Information about current and past mental health treatment was collected. As 
well as providing information about the sample of participants, these variables 
were used as covariates. To assess this, measures of (i) current receipt of 
treatment for the mental health disorder, and (ii) previous receipt of treatment 
for the mental health disorder, were included. The items read: “Are you 
currently receiving pharmacological or talking-therapy treatment for a mental 
health problem?”, and “Have you previously received pharmacological or 
talking-therapy treatment for a mental health problem?”. The response options 




Six vignettes were used to depict the effectiveness of talking-therapy for a 
CMHC. Participants were asked to imagine that they had been diagnosed with 
a condition. The six CMHCs were (i) chronic low self-esteem, (ii) depression, 
(iii) OCD, (iv) GAD, (v) PTSD, and (vi) social anxiety disorder. Each CMHC was 
briefly described in a pop-up window (Table 2.2). 
Six different outcomes were presented to participants (Table 2.3). These 
outcomes were hypothetical and this was described to participants before they 
saw the vignettes. The instructions read “The information shown about the 
effectiveness of talking-therapy on this page is fictional. Imagine that you have 
been diagnosed with [one of six CMHCs]. Treatment includes talking-therapy. 
In the graphic below you can see the outcomes for people who choose no 







Table 2.2: Brief pop-up window descriptors of conditions 
Chronic low self-esteem "Self-esteem refers to the overall opinion we have of 
ourselves and the value we place on ourselves as 
people. Low self-esteem means that the tone of this 
opinion is negative: for example, 'I'm unlovable' or 'I'm 
useless'. For some people low self-esteem can persist 
for a long time, that is, chronic" 
Depression "Depression is more than simply feeling unhappy or fed 
up for a few days.  We all go through spells of feeling 
down, but when you're depressed you feel persistently 
sad for weeks or months, rather than just a few days.   
Depression affects people in different ways and can 
cause a wide variety of symptoms.  They range from 
lasting feelings of sadness and hopelessness, to losing 
interest in the things you used to enjoy and feeling very 
tearful. Many people with depression also have 
symptoms of anxiety.  There can be physical symptoms 
too, such as feeling constantly tired, sleeping badly, 
having no appetite or sex drive, and complaining of 
various aches and pains." 
Obsessive compulsive disorder 
(OCD) 
"Obsessive Compulsive Disorder (OCD) is a mental 
health condition where a person has obsessive thoughts 
and compulsive behaviour.   For example, someone 
who is obsessively scared they will catch a disease may 
feel the need to have a shower every time they use a 
toilet." 
Generalised anxiety disorder 
(GAD) 
"People with Generalised Anxiety Disorder (GAD) find it 
hard to control their worries. Their feelings of anxiety are 
more constant and often affect their daily life. GAD is a 
long-term condition which causes you to feel anxious 
about a wide range of situations and issues, rather than 
one specific event. People with GAD feel anxious most 
days and often struggle to remember the last time they 
felt relaxed." 
Post-traumatic stress disorder 
(PTSD) 
"Post-Traumatic Stress Disorder (PTSD) is an anxiety 
disorder caused by very stressful, frightening or 
distressing events.   Someone with PTSD will often 
relive the traumatic event through nightmares and 
flashbacks, and they may experience feelings of 
isolation, irritability and guilt. They may also have 
problems sleeping, such as insomnia, and find 
concentrating difficult.  These symptoms are often 
severe and persistent enough to have a significant 
impact on the person's day-to-day life." 
Social anxiety disorder "Social Anxiety Disorder is an anxiety disorder 
characterized by intense fear in social situations causing 
considerable distress and impaired ability to function in 
at least some parts of daily life. Social anxiety disorder 
typically involves a persistent, intense, chronic fear of 
being judged by others and of being humiliated by one's 
own actions. Physical symptoms often accompanying 
social anxiety disorder include excessive blushing, 




Table 2.3: Combinations of treatment outcomes 
Label ARR B_RISK RRR 
Vignette 5/10=50 5% 10% 50% 
Vignette 15/30=50 15% 30% 50% 
Vignette 5/30=17 5% 30% 17% 
Vignette 15/90=17  15% 90% 17% 
Vignette 5/90=6 5% 90% 6% 
Vignette 45/90=50 45% 90% 50% 
 
The outcomes were presented with pictographs using icon-arrays and with 
written text. A screenshot of how the vignettes were presented is shown in 
Figure 2.3. The information depicting the effectiveness of talking therapy for the 
respective CMHCs was designed according to current best practice guidelines 
for communicating medical risks and treatments (Fagerlin, Zikmund-Fisher, & 
Ubel, 2011; Zikmund-Fisher, Fagerlin, & Ubel, 2010). Understanding the 
effectiveness of treatments is best when information is presented with the 
B_RISK, in natural frequencies, with pictographs, and using an incremental risk 
format (i.e. ARR) to highlight how treatment changes risks from the pre-existing 
B_RISK (Fagerlin et al., 2011; Gigerenzer et al., 2007). 
The icon arrays showed the outcomes for 100 people with the respective 
condition who did not receive treatment after 5 years: (i) symptom free with 
blue dots, and (ii) not symptom free with red dots (i.e. B_RISK). The outcomes 
for 100 people with the respective condition who received treatment after 5 
years were depicted as: (i) symptom free with blue dots, (ii) symptom free 
because of talking-therapy with green dots (i.e. ARR), and (iii) not symptom 
free with red dots (i.e. risk in treatment group).  
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Figure 2.3: Screenshot of outcomes for conditions 
 
The written text described those with the respective condition who did not 
receive treatment who were symptom free after 5 years “[xx] out of 100 people 
would be symptom free in 5 years”. Written text also described those with the 
respective condition who received treatment and had been helped by the 
treatment (i.e. ARR) “[xx] more people out of 100 would be symptom free 
because of talking-therapy in 5 years”.  
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A potential contaminating factor is that participants may have specific views 
about certain CMHCs. For example, they may view recovery without treatment 
as more likely from one CMHC than another. To avoid specific view about 
certain CMHCs affecting the results, the six CMHCs and the six outcomes were 
arranged differently, at random, for each participant. This was achieved with an 
algorithm computed in the online questionnaire. The order in which the 
vignettes were shown was also randomised. A similar method has been used 
previously (Vogt et al., 2012). 
The challenge in testing whether the B_RISK, the ARR, and the RRR have 
independent impacts on the perceived treatment effectiveness, is that they are 
linked to each other and cannot be varied independently. For example, holding 
constant the B_RISK (e.g. at 30%), an increase in one measure of treatment 
effectiveness (e.g. ARR: 5 to 15) is mirrored with an increase in the other 
measure of treatment effectiveness (e.g. RRR: 17% to 50%). However, while 
treatment effect and B_RISK cannot be varied independently, their relation is 
not parallel. This non-parallel relation can be used to assess the impact of each 
factor on perceptions of treatment effectiveness. The reason is that perceptions 
of treatment effectiveness should follow this non-parallel relationship between 
the ARR, the RRR, and the B_RISK, if each factor influences perceptions of 
treatment effectiveness. The outcomes on the six vignettes were selected 
specifically to test the non-parallel relationships. They were thus combined to 
test the independent impacts of the ARR, the RRR, and the B_RISK. 
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2.5.1. Vignettes for Hypothesis 1: B_RISK 
An increase in the ARR (i.e. 5 to 15), at a low RRR (i.e. RRR of 17%) increases 
the B_RISK strongly (i.e. B_RISK: 30% to 90%), whereas the same increase in 
the ARR at a large RRR (i.e. RRR of 50%), increases the B_RISK less (i.e. 
B_RISK: 10% to 30%; see Table 2.4), manifesting in a non-parallel relation 
between the three variables (see Figure 2.4).  
This non-parallel relation can be used to assess the postulated negative impact 
of the B_RISK on perceptions of treatment effectiveness, because perceptions 
of treatment effectiveness should follow this non-parallel relationship if the 
B_RISK influences treatment perceptions. Thus, if higher B_RISKs negatively 
influence treatment perception then the rapid increase in the B_RISK seen at a 
RRR of 17% and a ARR of 15% should result in suppressed perceptions of 
treatment effectiveness in Vignette 15/90=17. 


























Table 2.4: Vignettes used to keeping the differences in the ARR and the RRR constant
 ARR = 5% ARR = 15% Difference 
RRR=50% 
Vignette 5/10=50 
ARR      = 5% 
B-RISK = 10% 
RRR      = 50% 
 
Vignette 15/30=50 
ARR      = 15% 
B-RISK = 30% 
RRR      = 50% 
 
 
ARR_diff      = 10% 
B-RISK_diff = 20% 
RRR_diff      = 0% 
RRR=17% 
Vignette 5/30=17 
ARR      = 5% 
B-RISK = 30% 
RRR      = 17% 
 
Vignette 15/90=17  
ARR      = 15% 
B-RISK = 90% 
RRR      = 17% 
 
 
ARR_diff      = 10% 
B-RISK_diff = 60% 
RRR_diff      = 0% 
Difference 
ARR_diff      = 0% 
B-RISK_diff = 20% 
RRR_diff      = 33% 
ARR_diff      = 0% 
B-RISK_diff = 60% 
RRR_diff      = 33% 
Total ARR_diff       = 0% 
Total B-RISK_diff  = 40% 
Total RRR_diff       = 0% 
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2.5.2. Vignettes for Hypothesis 2: ARR 
An increase in the B_RISK (i.e. 30% to 90%), at a low RRR (i.e. 17%) 
increases the ARR less (i.e. 5% to 15%), whereas the same increase in the 
B_RISK at a large RRR (i.e. 50%), increases the ARR more (i.e. 15% to 45%; 
see Table 2.5), manifesting in a non-parallel relation between the three 
variables (see Figure 2.5).  
This non-parallel relation can be used to assess the impact of the ARR on 
perceptions of treatment effectiveness, because perceptions of treatment 
effectiveness should follow this non-parallel relationship if the ARR influences 
treatment perceptions. Thus, if a higher ARR positively influences treatment 
perception then the rapid increase in the ARR seen at a RRR of 50% and a 
B_RISK of 90% should boost perceptions of treatment effectiveness in Vignette 
45/90=50. 




























Table 2.5: Vignettes used to keeping the differences in the B_RISK and the RRR constant 
 
 B-RISK = 90% B-RISK = 30% Difference 
RRR=50% 
Vignette 45/90=50 
ARR      = 45% 
B-RISK = 90% 
RRR      = 50% 
 
Vignette 15/30=50 
ARR      = 15% 
B-RISK = 30% 
RRR      = 50% 
 
 
ARR_diff      = 30% 
B-RISK_diff = 60% 
RRR_diff      = 0% 
RRR=17% 
Vignette 15/90=17 
ARR      = 15% 
B-RISK = 90% 
RRR      = 17% 
 
Vignette 5/30=17  
ARR      = 5% 
B-RISK = 30% 
RRR      = 17% 
 
 
ARR_diff      = 10% 
B-RISK_diff = 60% 
RRR_diff      = 0% 
Difference 
ARR_diff      = 30% 
B-RISK_diff = 0% 
RRR_diff      = 33% 
ARR_diff      = 10% 
B-RISK_diff = 0% 
RRR_diff      = 33% 
Total ARR_diff       = 20% 
Total B-RISK_diff  = 0% 
Total RRR_diff       = 0% 
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2.5.3. Vignettes for Hypothesis 3: RRR 
An increase in the ARR (i.e. 5% to 15%), at a high B_RISK (i.e. 90%) increases 
the RRR less (i.e. 6% to 17%), whereas the same increase in the ARR at a low 
B_RISK (i.e. 30%), increases the RRR more (i.e. 17% to 50%; see Table 2.6), 
manifesting in a non-parallel relation between the three variable (see Figure 
2.6).  
This non-parallel relation can be used to assess the impact of the RRR on 
perceptions of treatment effectiveness, because perceptions of treatment 
effectiveness should follow this non-parallel relationship if the RRR influences 
treatment perceptions. If the RRR influences treatment perception then the 
rapid increase in the RRR seen at a B_RISK of 30% and an ARR of 15% 
should boost perceptions of treatment effectiveness in Vignette 15/30=50. 
 
























Table 2.6: Vignettes used to keeping the differences in the ARR and the B_RISK constant 
 ARR = 5% ARR = 15% Difference 
B-RISK = 
30% 
Vignette 5/30=17  
ARR      = 5% 
B-RISK = 30% 
RRR      = 17% 
 
Vignette 15/30=50 
ARR      = 15% 
B-RISK = 30% 
RRR      = 50% 
 
 
ARR_diff      = 10% 
B-RISK_diff = 0% 




ARR      = 5% 
B-RISK = 90% 
RRR      = 6% 
 
Vignette 15/90=17 
ARR      = 15% 
B-RISK = 90% 
RRR      = 17% 
 
 
ARR_diff      = 10% 
B-RISK_diff = 0% 
RRR_diff      = 11% 
Difference 
ARR_diff      = 0% 
B-RISK_diff = 60% 
RRR_diff      = 11% 
ARR_diff      = 0% 
B-RISK_diff = 60% 
RRR_diff      = 33% 
Total ARR_diff       = 0% 
Total B-RISK_diff  = 0% 




The analysis will commence by using simple bi-variate correlations across the 
variables. For the main analyses three separate 2 x 2 x 2 x 4 mixed within-
between factorials were constructed with the perceived effectiveness of talking-
therapy as the dependent variable, as outlined below. All analyses were 
conducted with IBM SPSS Version 19. 
2.6.1. Hypothesis 1: ‘Talking-therapies for conditions with higher 
B_RISKs are perceived as less effective.’ 
In order to test Hypothesis 1, a 2 x 2 x 2 x 4 mixed within-between subjects 
ANCOVA was used. The two within subjects factors are ARR (two levels: 5 vs. 
15) and RRR (two levels: 17% vs. 50%). The two between-subjects factors 
were mood (two levels: low vs. high) and numeracy (four levels: poor vs. fair 
vs. good vs. excellent). If a higher B_RISK negatively influences treatment 
perception then this would be indicated by an interaction between the RRR and 
the ARR: perceptions of treatment effectiveness should be suppressed by the 
large B_RISK (i.e. 90%) at a small RRR (i.e. 17%) and large ARR (i.e. 15%). If 
mood or numeracy moderated the impact of the B_RISK, then a three-way 
interaction would be seen between the ARR, the RRR, and mood or numeracy, 
respectively. ANCOVA is different from ANOVA because it allows the inclusion 
of covariates in order to control for potential confounding effects which can 
make the analysis statistically more efficient as compared to including these 
variables as additional factors in an ANOVA. The covariates can be continuous 
or dichotomous variables (Tabachnick & Fidell, 2001). A number of covariates 
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were added, including age, gender, education, and previous and past 
treatment. 
2.6.2. Hypothesis 2: ‘Talking-therapies with higher ARRs are perceived 
as more effective.’ 
In order to test Hypothesis 2, a 2 x 2 x 2 x 4 mixed within-between subjects 
ANCOVA was used. The two within subjects factors are B_RISK (two levels: 
30% vs. 90%) and RRR (two levels: 17% vs. 50%). The two between-subjects 
factors are mood (two levels: low mood vs. high mood) and numeracy (four 
levels: poor vs. fair vs. good vs. excellent). If a higher ARR positively influences 
treatment perceptions then this would be indicated by an interaction between 
the RRR and the B_RISK: perceptions of treatment effectiveness would be 
boosted by the large ARR (i.e. 45%) at a large B_RISK (i.e. 90%) and a large 
RRR (i.e. 50%). If mood or numeracy moderated the impact of the ARR, then a 
three-way interaction would be expected between the B_RISK, the RRR and 
mood or numeracy, respectively. A number of covariates were included to 
control for confounding factors, including age, gender, education, and previous 
and past treatment. 
2.6.3. Hypothesis 3 ‘Talking-therapies with higher RRRs are perceived 
as more effective’ 
In order to test Hypothesis 3, a 2 x 2 x 2 x 4 mixed within-between subjects 
ANCOVA was used. The two within subjects factors are B_RISK (two levels: 
30% vs. 90%) and ARR (two levels: 5% vs. 15%). The two between-subjects 
factors are mood (two levels: low mood vs. high mood) and numeracy (four 
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levels: poor vs. fair vs. good vs. excellent). If a higher RRR positively influences 
treatment perceptions then this would be indicated by an interaction between 
the B_RISK and the ARR: perceptions of treatment effectiveness should be 
boosted by the large RRR (i.e. 50%) at a small B_RISK (i.e. 30%) and a large 
ARR (i.e. 15%). If mood or numeracy moderated the impact of the RRR, then a 
three-way interaction would be expected between the B_RISK, the ARR and 
mood or numeracy, respectively. A number of covariates were included to 
control for confounding factors, including age, gender, education, and previous 
and past treatment. 
2.7. Sample size calculation  
The power calculation was performed for determining the impact of the B_RISK 
on perceptions of effectiveness. A previous study on the B_RISK detected a 
small to medium effect size (partial η2 (partial eta squared) = 0.0481) (Vogt et 
al., 2012). For factorial analysis of variance partial η2  approximates the η2 rules 
of thumb given as follows: small  = 0.02, medium = 0.13, large = 0.26 (Cohen, 
1988; Medical Research Council, 2013). The sample size for the current study 
was calculated conservatively with power at 0.90, with an alpha of 0.05 to 
detect a small to medium effect (partial η2 = 0.0481) in perceived effectiveness 
of treatments using a main effects and interactions analysis of covariance 
(ANCOVA) with seven covariates. G*Power calculated a necessary sample 
size of 210 (Erdfelder, Faul, & Buchner, 1996). 
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2.8. Data preparation 
Prior to the analysis, the variables were examined for accuracy of data entry, 
outliers, violations of assumptions, and missing values. The minimum and 
maximum values, means and standard deviations of all the variables were 
found to be plausible apart from two participants. These participants had 
entered age as 1000 and 100, respectively, and responded to all questions with 
the minimum value; these participants were removed from the dataset. No 
significant univariate outliers were detected in the dataset (Tabachnick & Fidell, 
2001).  
2.8.1. Normality  
Data was screened for normality examining skewness and kurtosis, both of 
which show zero in a perfectly normal distribution. The z score for skew and 
kurtosis was tested conservatively (p < 0.001), with scores < 3.29 considered 
normal (Tabachnick & Fidell, 2001).  
None of the perceived effectiveness judgments of the vignettes showed skew: 
Vignette 5/10=50 (z = 1.40, p > 0.001), Vignette 15/30=50 (z = -0.50, p > 
0.001), Vignette 5/30=17 (z = 1.39, p > 0.001), Vignette 15/90=17 (z = 1.36, p > 
0.001), Vignette 5/90=6 (z = 2.23, p > 0.001), and Vignette 45/90=50 (z = -
2.87, p > 0.001). Age (z = -0.71, p > 0.001), numeracy (z = 1.57, p > 0.001), 
and education (z = -3.05, p > 0.001) were not skewed either. None of the 
perceived effectiveness judgments of the vignettes showed kurtosis: Vignette 
5/10=50 (z = -1.89, p > 0.001), Vignette 15/30=50 (z = -1.86, p > 0.001), 
Vignette 5/30=17 (z = -1.84, p > 0.001), Vignette 15/90=17 (z = -1.79, p > 
0.001), Vignette 5/90=6 (z = -1.63, p > 0.001), and Vignette 45/90=50 (z = -
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1.10, p > 0.001). Age (z = -1.09, p > 0.001), numeracy (z = -1.69, p > 0.001), 
and education (z = -1.10, p > 0.001) showed no kurtosis either. The remaining 
variables were dichotomous and normality does not apply. 
2.8.2. Missing data 
Answers for the perception about the effectiveness of talking-therapy were 
required and could not be skipped, resulting in no missing data. There were 
few missing data in the other variables. A cut-off that is often used to indicate 
needing to address missing data is 5% (Tabachnick & Fidell, 2001). There was 
one variable that exceeded this cut-off. This was the PHQ-4 score with 16 
missing units (8% missing data). Because the variables enter the ANCOVA 
jointly, the combination of several variables with missing data, albeit each one 
with few missing data, can add up to cause a substantial loss of degrees of 
freedom and thus power. To prevent this, missing data points were replaced 
with the median score on age, gender, current treatment, past treatment, 
education, and mood. The median score on each variable was used to facilitate 
further analysis in the ANCOVA (e.g. keep variables dichotomous) (Tabachnick 
& Fidell, 2001). 
2.8.3. Multicollinearity 
One additional assumption for ANCOVA is the absence of multicollinearity. 
Multicollinearity is the presence of high correlations (i.e.  > 0.9) between the 
CVs (Tabachnick & Fidell, 2001). If there is more than one CV and they are 
highly correlated they will cancel each other out of the equations. No 
multicollinearity was detected between gender, age, education, and present 





To gain an overview over the data, bi-variate correlations were computed for 
the six judgements of effectiveness and the covariates, demographic and 
psychosocial variables, as well as numeracy. See Table 3.1 for an overview. 
3.1.1 Relation between six judgments of effectiveness  
All judgements of effectiveness for the six different vignettes were significantly 
and positively correlated, with coefficients ranging from r = 0.454 to r = 0.844. 
This showed that participants’ judgements of the vignettes was consistent to 
the extent that individuals who judged the effectiveness of talking-therapy as 
high in one vignette were likely to rate it as high in others as well. 
3.1.2 Relation between covariates 
Several significant correlations were detected among the covariates. Gender 
was correlated with numeracy (r = -0.242, p = 0.001), showing that male 
participants were more numerate. Education was correlated with numeracy (r = 
0.254, p < 0.001), showing that numeracy increased with more education. 
Education was also correlated with mood (r = -0.192, p = 0.008), showing that 
those with more education had better mood. Currently receiving treatment for a 
CMHC was associated with past treatment for a CMHC (r = 0.469, p = 0.001). 
3.1.3 Relation between six judgments of effectiveness and covariates  
The correlation coefficients showed that there were few relationships between 
the covariates and the judgments of effectiveness. Indeed, out the 42 
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combinations, only four correlations were significant. Education was correlated 
with the effectiveness judgement of Vignette 5/30=17 (r = -0.159, p = 0.019), 
Vignette 5/90=6 (r = -0.168, p = 0.024), and Vignette 5/10=50 (r = -0.149, p = 
0.039). In all these correlations, those with higher education judged the 
effectiveness of treatments as lower than those with lower education. 
Numeracy was also associated with the effectiveness judgement of 5/30=17 (r 
= -0.146, p = 0.041); more numerate participants judged talking-therapy in this 
vignette as less effective.
67 
 
Table 3.1: Pearson’s r correlations 
Notes: **. Correlation is significant at the 0.01 level (2-tailed); *. Correlation is significant at the 0.05 level (2-tailed); Gender (male/female); Ctreat = Current Treatment 
(no/yes); Ptreat = Past Treatment (no/yes); Num = Numeracy; Mood (normal/low); Edu = Education (low/high) 15/90=17 (perceived effectiveness); 5/30=17 (perceived 
effectiveness); 45/90=50 (perceived effectiveness); 5/90=6 (perceived effectiveness); 5/10=50 (perceived effectiveness); 15/30=50 (perceived effectiveness).
 Age Gender Ctreat Ptreat Num Edu Mood 15/90=17 5/30=17 45/90=50 5/90=6 5/10=50 15/30=50 
Age 1 -.055 .000 .025 -.050 .067 -.132 .076 .032 .036 .046 .023 .060 
Gender -.055 1 .092 .130 -.242
**
 .131 -.037 -.097 -.114 .005 -.129 -.123 -.069 
Ctreat .000 .092 1 .469
**
 -.043 -.088 -.061 -.027 -.055 .063 -.064 -.077 -.059 
Ptreat .025 .130 .469
**
 1 .077 .071 -.028 -.067 -.101 .053 -.121 -.087 -.075 
Num -.050 -.242
**
 -.043 .077 1 .254
**
 -.010 -.095 -.146
*
 .103 -.107 -.099 -.065 











Mood -.132 -.037 -.061 -.028 -.010 -.192
**
 1 -.063 -.046 -.124 -.036 -.074 -.091 












































































3.2. Hypothesis 1 – interaction between RRR * ARR 
Hypothesis 1:  Talking-therapies for conditions with higher B_RISKs are 
   perceived as less effective. 
In order to test Hypothesis 1, a 2 x 2 x 2 x 4 mixed within-between subjects 
ANCOVA was run controlling for age, gender, education, previous and past 
treatment. The two-way interaction between the ARR and the RRR [F(1, 191) = 
5.292, p = 0.023, partial η2 = 0.027, Table 3.2] was significant. The ANCOVA 
also showed that both, the main effect for the RRR [F(1, 191) = 29.666, p < 
0.001, partial η2 = 0.134, Table 3.2] and for the ARR [F(1, 191) = 5.363, p = 
0.022, partial η2 = 0.027, Table 3.2] were significant. However, these main 
effects are interpreted considering the interaction between these factors 
(Tabachnick & Fidell, 2001).  
Examining the means of these factors more closely (Figure 3.1), the interaction 
suggests that the RRR has less influence on the perceived effectiveness of 
talking-therapy at a low ARR (i.e. 5%). Similarly, the interaction suggests that 
that the ARR has less influence on the perceived effectiveness of talking-
therapy at a low RRR (i.e. 17%). These results can be accounted by 
considering the B_RISK, to the extent that a larger B_RISK decreases the 
perceived treatment effectiveness of the talking-therapy.  
At a low ARR (i.e. 5%) the B_RISK of Vignette 5/30=17 is just 20% higher than 
that of Vignette 5/10=50. However, at a high ARR (i.e. 15%) the B_RISK of 
Vignette 15/90=17 is 60% higher than that of Vignette 15/30=50, relatively 
depressing the perceived effectiveness of Vignette 15/90=17. Similarly, at a 
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high RRR (i.e. 50%) the B_RISK of Vignette 15/30=50 is just 20% higher than 
that of Vignette 5/10=50. However, at a low RRR (i.e. 17%) the B_RISK of 
Vignette 15/90=17 is 60% higher than that of Vignette 5/30=17, relatively 
depressing the perceived effectiveness of Vignette 15/90=17. The results 
therefore suggest that the B_RISK negatively influences perceptions of the 
effectiveness of talking-therapy for CMHCs.  
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3.2.1. No moderating effects 
Neither the three-way interaction between the ARR, the RRR and numeracy 
[F(3, 191) = 1.384, p = 0.249, partial η2 = 0.021, Table 3.2], nor the three-way 
interaction between the ARR, the RRR and mood [F(1, 191) = 0.082, p = 0.775, 
partial η2 < 0.001, Table 3.2] was significant. There was also no other 
significant three-way interaction with a covariate and no significant two-way 
interaction (Table 3.2). This suggests that individuals were influenced by the 
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B_RISK and that this influence was not moderated by numeracy, mood, or any 
of the other covariates. 
3.2.2. Numeracy influences perceived effectiveness  
The main effect of numeracy was significant [F(3, 191) = 2.92, p = 0.035, 
partial η2 = 0.044, Table 3.2]. Examining the means it appears that those with 
worse numeracy judge talking-therapies as more effective than those with 
better numeracy (Figure 3.2). Least significant difference (LSD) pairwise 
comparisons of the means show that indeed those with poor numeracy judged 
talking-therapies as more effective than those with fair numeracy [mean-
difference = 11.81, p = 0.016] or excellent [mean-difference = -12.84, p = 
0.047]. There were no further significant differences across different levels of 
numeracy. 
Figure 3.2: Main effect of numeracy (mean, standard error) 
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3.2.3. Gender influences perceived effectiveness 
Another main effect was significant. This was gender [F(1, 191) = 4.12, p = 
0.044, partial η2 = 0.021, Table 3.2]. The means show that women (mean = 
47.91, SE = 2.60) judged talking-therapies as less effective than men (mean = 




Table 3.2: ANCOVA for RRR x ARR x Numeracy x Mood 




RRR 1 29.666 <.001 .134 1.000 
RRR * Num 3 .979 .404 .015 .264 
RRR * Mood 1 .048 .828 <.001 .055 
RRR * Ctreat 1 .507 .477 .003 .109 
RRR * Ptreat 1 .049 .826 <.001 .056 
RRR * Gender 1 1.851 .175 .010 .273 
RRR * Age 1 1.718 .192 .009 .256 
RRR * Edu 1 .635 .426 .003 .125 
ARR 1 5.363 .022 .027 .635 
ARR * Num 3 .745 .526 .012 .208 
ARR * Mood 1 .370 .544 .002 .093 
ARR * Ctreat 1 .452 .502 .002 .103 
ARR * Ptreat 1 .121 .728 .001 .064 
ARR * Gender 1 .119 .730 .001 .064 
ARR * Age 1 .060 .807 <.001 .057 
ARR * Edu 1 .013 .911 <.001 .051 
RRR * ARR 1 5.292 .023 .027 .629 
RRR * ARR * Num 3 1.384 .249 .021 .364 
RRR * ARR * Mood 1 .082 .775 <.001 .059 
RRR * ARR * Ctreat 1 <.001 .994 <.001 .050 
RRR * ARR * Ptreat 1 .080 .777 <.001 .059 
RRR * ARR * Gender 1 .238 .626 .001 .077 
RRR * ARR * Age 1 .057 .811 <.001 .057 
RRR * ARR * Edu 1 .064 .801 <.001 .057 
Num 3 2.923 .035 .044 .689 
Mood 1 .664 .416 .003 .128 
Ctreat 1 .773 .381 .004 .141 
Ptreat 1 .629 .429 .003 .124 
Gender 1 4.122 .044 .021 .524 
Age 1 .333 .564 .002 .089 
Edu 1 3.415 .066 .018 .452 
Error(RRR*ARR) 191     
Notes: Edu = Education; Ctreat = Current Treatment; Ptreat = Past Treatment; Num = Numeracy. 
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3.3. Hypothesis 2 – Interaction between RRR * B_RISK 
Hypothesis 2:  Talking therapies with higher ARRs are perceived as more 
   effective. 
In order to test Hypothesis 2, a 2 x 2 x 2 x 4 mixed within-between subjects 
ANCOVA was run controlling for age, gender, education, previous and past 
treatment. The mixed ANCOVA showed that the two-way interaction between 
the B_RISK and the RRR [F(1, 191) = 15.74, p < 0.001, partial η2 = 0.076, 
Table 3.3] was significant. The ANCOVA also showed that both the main effect 
of the RRR [F(1, 191) = 165.462, p < 0.001, partial η2 = 0.464, Table 3.3] and 
that of the B_RISK [F(1, 191) = 25.495, p < 0.001, partial η2 = 0.118, Table 3.3] 
was significant. 
Examining the means of these factors more closely (Figure 3.3), the significant 
interaction suggests that the RRR has less influence on the perceived 
effectiveness of talking-therapy at a low B_RISK (i.e. 30%). Similarly, the 
significant interaction suggests that that the B_RISK has more influence on the 
perceived effectiveness of talking-therapy at a high RRR (i.e. 50%). These 
results can be accounted for by considering the ARR, to the extent that a larger 
ARR increases the perceived effectiveness of the talking-therapy. 
At a low B_RISK (i.e. 30%) the ARR of Vignette 15/30=50 is just 10% higher 
than that of Vignette 5/30=17. However, at a high B_RISK (i.e. 90%) the ARR 
of Vignette 45/90=50 is 30% higher than that of Vignette 15/90=17, relatively 
boosting the perceived effectiveness of Vignette 45/90=50. Similarly, at a low 
RRR (i.e. 17%) the ARR of Vignette 15/90=17 is just 10% higher than that of 
Vignette 5/90=17. However, at a high RRR (i.e. 50%) the ARR of Vignette 
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45/90=50 is 30% higher than that of Vignette 15/30=50, relatively boosting the 
perceived effectiveness of Vignette 45/90=50. The results therefore suggest 
that the ARR positively influences perceptions of the effectiveness of talking-
therapy for CMHCs. 
Figure 3.3: Interaction between B_RISK * RRR (mean, standard error) 
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3.3.1. Moderating effects - numeracy 
The three-way interaction between the B_RISK, the RRR, and numeracy was 
not significant [F(3, 191) = 1.428, p = 0.236, partial η2 = 0.022, Table 3.3]. The 
three-way interaction between the B_RISK, the RRR, and mood was also not 
significant [F(1, 191) = 0.066, p = 0.798, partial η2 < 0.001, Table 3.3]. There 
were no other three-way interactions between the B_RISK, the RRR and any of 
the covariates (Table 3.3). The results therefore suggest that individuals were 
influenced by the ARR, as indicated by the significant two-way interaction 
75 
 
between the ARR and the RRR, and that this influence is not moderated by 
numeracy, mood, or any of the other included covariates. 
However, the two-way interactions between the B_RISK and numeracy [F(3, 
191) = 2.70, p = 0.047, partial η2 = 0.041, Table 3.3] and between the RRR and 
numeracy were significant [F(3, 191) = 5.75, p = 0.001, partial η2 = 0.083, Table 
3.3]. Because the two-way interaction between the B_RISK and the RRR was 
significant, indicating that the ARR influences results, neither the interaction 
between the B_RISK and numeracy, nor the interaction between the RRR and 
numeracy can be interpreted easily. That is, because the ARR is confounding 
these interactions. 
The means of the interaction between the RRR and numeracy show that those 
with better numeracy differentiated more between talking-therapy with different 
RRRs, than those with poorer numeracy (Figure 3.4); with more numerate 
participants considering talking-therapy with a RRR of 17% less effective than 
a talking-therapy with a RRR of 50%. The means of the interaction between the 
B_RISK and numeracy show a similar pattern, in that those with better 
numeracy differentiated more between talking-therapy with different B_RISKs 
than those with poorer numeracy (Figure 3.4); with more numerate participants 




Figure 3.4: Interactions between with Numeracy (mean, standard error) 
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However, both the B_RISK and the RRR are confounded by the ARR. That is, 
talking-therapies with a higher B_RISK also have a higher ARR, and talking-
therapies with a lower RRR also have a lower ARR. What these findings thus 
also show is that participants with worse numeracy respond less to differences 
in the ARR. 
3.3.2. Moderating effects - gender 
There was also a significant two-way interaction between the RRR and gender 
[F(1, 191) = 8.816, p = 0.003, partial η2 = 0.044, Table 3.3]. The means show 
that women considered talking-therapy with a RRR of 17% as less effective 
than men, but not talking-therapy with a RRR of 50% (Figure 3.5).  
Figure 3.5: Interaction between RRR * Gender (mean, standard error) 































They may therefore be more sensitive to decreases in the RRR. However, the 
RRR in this analysis is confounded by the ARR, and thus the results also show 
that women consider treatments with a lower ARR as less effective than men; 
that is, they are more sensitive to decreases in the ARR than men. The 
interaction between the B_RISK and gender was not significant [F(1, 191) = 




Table 3.3: ANCOVA for RRR x B_RISK x Numeracy x Mood 




RRR 1 165.462 <.001 .464 1.000 
RRR * Num 3 5.746 .001 .083 .947 
RRR * Mood 1 1.489 .224 .008 .229 
RRR * Ctreat 1 1.687 .196 .009 .253 
RRR * Ptreat 1 1.568 .212 .008 .238 
RRR * Gender 1 8.816 .003 .044 .840 
RRR * Age 1 .020 .888 <.001 .052 
RRR * Edu 1 3.482 .064 .018 .459 
B_RISK 1 25.495 <.001 .118 .999 
B_RISK * Num 3 2.700 .047 .041 .650 
B_RISK * Mood 1 .295 .588 .002 .084 
B_RISK * Ctreat 1 1.958 .163 .010 .286 
B_RISK * Ptreat 1 .592 .443 .003 .119 
B_RISK * Gender 1 1.818 .179 .009 .269 
B_RISK * Age 1 .013 .911 <.001 .051 
B_RISK * Edu 1 1.323 .251 .007 .208 
RRR * B_RISK 1 15.737 <.001 .076 .977 
RRR * B_RISK * Num 3 1.428 .236 .022 .375 
RRR * B_RISK * Mood 1 .066 .798 <.001 .058 
RRR * B_RISK * Ctreat 1 1.867 .173 .010 .275 
RRR * B_RISK * Ptreat 1 .391 .532 .002 .095 
RRR * B_RISK * Gender 1 1.057 .305 .006 .176 
RRR * B_RISK * Age 1 1.473 .226 .008 .227 
RRR * B_RISK * Edu 1 1.316 .253 .007 .207 
Num 
3 2.207 .089 .034 .554 
Mood 
1 1.012 .316 .005 .170 
Ctreat 
1 .111 .739 .001 .063 
Ptreat 
1 .363 .547 .002 .092 
Gender 
1 2.032 .156 .011 .294 
Age 
1 .542 .463 .003 .113 
Edu 
1 1.935 .166 .010 .283 
Error(RRR*B_RISK) 191     
Notes: Edu = Education; Ctreat = Current Treatment; Ptreat = Past Treatment; Num = Numeracy. 
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3.4. Hypothesis 3 – No interaction between ARR * B_RISK 
Hypothesis 3:  Talking therapies with higher RRRs are perceived as more 
   effective. 
In order to test Hypothesis 3, a 2 x 2 x 2 x 4 mixed within-between subjects 
ANCOVA was run controlling for age, gender, education, previous and past 
treatment. The mixed ANCOVA showed that the two-way interaction between 
the ARR and the B_RISK [F(1, 191) = 1.858, p = 0.174, partial η2 = 0.010] was 
not significant (Table 3.4). This suggests that participants are not responding to 
different levels of the RRR.  
The ANCOVA showed that the main effect of the ARR was significant [F(1, 
191) = 75.838, p < 0.001, partial η2 = 0.284, Table 3.4]. The means show that 
talking-therapies with a higher ARR are perceived as more effective than 
talking-therapies with a lower ARR (Figure 3.6). The ANCOVA also showed 
that the main effect of the B_RISK was significant [F(1, 191) = 8.629, p = 
0.004, partial η2 = 0.043, Table 3.4]. The means show that talking-therapies for 
conditions with a higher B_RISK are perceived as less effective than talking-
therapies for conditions with a lower B_RISK (Figure 3.6).  
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3.4.1. No moderating effects 
There was no three-way interaction between the ARR, the B_RISK, and 
numeracy [F(3, 191) = 1.064, p = 0.365, partial η2 = 0.016, Table 3.4] and no 
three-way interaction between the ARR, the B_RISK, and mood [F(1, 191) = 
0.039, p = 0.844, partial η2 < 0.001, Table 3.4]. There was also no other 
significant three-way interaction with a covariate and no significant two-way 
interaction (Table 3.4).  
3.4.2. Gender influences perceived effectiveness  
However, the between-subjects main effect of gender was significant [F(1, 191) 
= 4.013, p = 0.043, partial η2 = 0.021, Table 3.4]. The means show that women 
(mean = 46.818, SE = 2.60) judged talking-therapies as less effective than men 
(mean = 53.599, SE = 3.955).  
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Table 3.4: ANCOVA for ARR x B_RISK x Numeracy x Mood 




ARR 1 75.838 <.001 .284 1.000 
ARR * Num 3 1.679 .173 .026 .435 
ARR * Mood 1 .777 .379 .004 .142 
ARR * Ctreat 1 .493 .483 .003 .108 
ARR * Ptreat 1 1.237 .268 .006 .198 
ARR * Gender 1 2.672 .104 .014 .370 
ARR * Age 1 1.162 .282 .006 .189 
ARR * Edu 1 1.045 .308 .005 .174 
B_RISK 1 8.629 .004 .043 .832 
B_RISK * Num 3 1.513 .213 .023 .395 
B_RISK * Mood 1 .028 .867 <.001 .053 
B_RISK * Ctreat 1 .018 .893 <.001 .052 
B_RISK * Ptreat 1 .103 .749 .001 .062 
B_RISK * Gender 1 .096 .757 .001 .061 
B_RISK * Age 1 .044 .834 <.001 .055 
B_RISK * Edu 1 .039 .843 <.001 .054 
ARR * B_RISK 1 1.858 .174 .010 .274 
ARR * B_RISK * Num 3 1.064 .365 .016 .285 
ARR * B_RISK * Mood 1 .039 .844 <.001 .054 
ARR * B_RISK * Ctreat 1 .479 .490 .002 .106 
ARR * B_RISK * Ptreat 1 .158 .692 .001 .068 
ARR * B_RISK * Gender 1 .349 .555 .002 .090 
ARR * B_RISK * Age 1 .093 .761 <.001 .061 
ARR * B_RISK * Edu 1 .023 .881 <.001 .053 
Num 
3 2.580 .055 .039 .628 
Mood 
1 .445 .506 .002 .102 
Ctreat 
1 .684 .409 .004 .130 
Ptreat 
1 .997 .319 .005 .168 
Gender 
1 4.013 .047 .021 .513 
Age 
1 .530 .467 .003 .112 
Edu 
1 3.418 .066 .018 .452 
Error(ARR*B_RISK) 191     





The results showed that Hypothesis 1 was confirmed, suggesting that 
participants considered the B_RISK of the condition when they judged the 
effectiveness of a talking-therapy. The results also showed that Hypothesis 2 
was confirmed, demonstrating that participants also considered the ARR of a 
talking-therapy when they judged its effectiveness at treating a CMHC. Finally, 
the results showed that Hypothesis 3 was not confirmed, the current study did 
not show that the RRR influenced participants’ judgments of the effectiveness 
of a talking-therapy because the confounding variables ARR and B_RISK could 
not be excluded as alternative explanations. 
There was no evidence that mood moderated the impact of the B_RISK, the 
ARR, or the RRR. There was some evidence that participants who failed to 
answer any of the numeracy questions were not responding to the RRR or the 
B_RISK. However, these findings were confounded by the ARR and an 
alternative explanation is that participants with worse numeracy skills are not 
sensitive to the ARR.  
Finally, there was some evidence that women and those with better numeracy 




4.2 Hypothesis 1: B_RISK 
The results showed that participants appeared to respond to the B_RISK of the 
condition when judging the effectiveness of a talking therapy. The current 
results therefore mirror those obtained in the study on judgments about 
medications for cancer (Vogt et al., 2012). It is thus only the second study that 
has documented that the B_RISK has an effect on perceptions of treatment 
effectiveness, which is independent from that of measures of treatment 
effectiveness. Previous studies, albeit reporting on the impact of the B_RISK 
on the perceived treatment effectiveness did not separate it from the 
confounding factors RRR and ARR (e.g. Fetherstonhaugh et al., 1997; 
Friedrich et al., 1999; Gyrd-Hansen et al., 2002; V. K. Smith & Desvousges, 
1987). It is the first study that documented this effect for treatments aimed at 
CMHCs. The extent of the impact of the B_RISK was such that even talking-
therapy with an ARR of 15 (Vignette 15/90=17) was not perceived as more 
effective than a talking-therapy with an ARR of only 5 (Vignette 5/30=17), 
because of the high B_RISK in the former. 
An interpretation that could be drawn as a consequence of this study is that 
people who judge talking-therapies on the basis of the B_RISK are committing 
an error of judgment. They erroneously discredit talking-therapies for bad 
outcomes that are due to a naturally low rate of recovery and credit talking-
therapies for high rates of recovery that are not caused by the treatment. This 
error has been named the ‘B_RISK integration error’ because participants 




4.2.1 Why are people influenced by the B_RISK when judging treatment 
effectiveness? 
If individuals are making an erroneous decision when they evaluate the 
effectiveness of the talking-therapy on the basis of the B_RISK of the condition, 
the question arises as to the reason for this decision making error. A number of 
explanations may account for this findings. 
“Persuasiveness of the RRR” 
Some researchers have tried to explain the impact of the B_RISK in terms of 
the greater persuasiveness of the RRR as compared to the ARR on treatment 
perception (Baron, 1997). However, this explanation equates the impact of the 
B_RISK with that of the RRR, although they are conceptually and 
mathematically different factors. Thus, this explanation does not match the 
current findings which showed that the B_RISK had an effect on perceptions of 
treatment effectiveness that could not be accounted for by differences in the 
RRR. 
“Psychological numbing” 
Previous research on the B_RISK explained this apparent phenomenon as a 
result of "psychological numbing" or the “drop in the bucket” effect 
(Fetherstonhaugh et al., 1997). A tendency for individuals to rate an 
intervention saving a fixed number of lives to be less worth investing in, the 
greater the total number of lives that are not helped. In subsequent 
experiments participants were prompted to engage in more thoughtful 
processing about similar judgements, but these manipulations had no impact 
on "psychological numbing" (Friedrich et al., 1999). The researchers 
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interpreted this as indicating that rather than being the result of careless 
thinking, "psychological numbing" appears to be the result of a kind of 
reasoning that is meaningful to individuals.  
While the above studies did not consider alternative explanations for their 
findings, namely the RRR, the processes underlying the B_RISK in the current 
study are consistent with the "psychological numbing" explanation. That is, 
talking-therapy for a population with a CMHC that has a large B_RISK might 
seem like a “drop in the bucket”, because many people have an adverse 
outcome despite treatment. The current study also showed that the impact of 
the B_RISK was not moderated by numeracy, which is consistent with the 
previous findings on “psychological numbing”, showing that it was not 
moderated by the degree of processing (Friedrich et al., 1999).  
“Affect heuristic” 
Another explanation for the impact of the B_RISK in the current study is what 
has been described as the “affect heuristic”. Early studies of risk perception 
found that, whereas risk and benefit tend to be positively correlated in the real 
world (e.g. a powerful technology/intervention also tends to have many adverse 
impacts, e.g. nuclear power), they are often negatively correlated in people’s 
minds (Fischhoff, Slovic, Lichtenstein, Read, & Combs, 1978). The reason for 
this negative correlation is postulated to be the “affect heuristic” (Slovic, Peters, 
Finucane, & MacGregor, 2005). 
While exploring the negative correlation between the perceived risk and the 
perceived benefit of an intervention/behaviour it was found that it depended on 
the positive or negative affect associated with that intervention/behaviour 
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(Alhakami & Slovic, 1994). It suggested that people based their judgments of 
an intervention/behaviour not only on what they thought about it but also on 
how they felt about it. If feelings toward an intervention/behaviour were 
favourable, it was more likely that risks were judged as low and the benefits as 
high. If feelings toward intervention/behaviour were unfavourable, the opposite 
was more likely, risks were judged as high and the benefits as low. The “affect 
heuristic” postulates that affect comes prior to, and directs, judgments of risk 
and benefit (Slovic et al., 2005). 
Based on the premise that peoples’ decisions depend on their affect, it was 
examined whether providing information about either the risks or benefits of an 
intervention/behaviour could change the affective view of the 
intervention/behaviour, which in turn might guide the perception of either 
benefits or risks (Finucane, Alhakami, Slovic, & Johnson, 2000). It was found 
that information stating the benefits as high for a technology such as nuclear 
power, lead to more positive affect, which, in turn, decreased the perceived risk 
of nuclear power. Similarly, providing information to increase the perceived risk 
decreased the perceived benefit of a technology via more negative affect. 
The current finding may thus be explained by changes in the affect, caused by 
presenting CMHCs with low and high B_RISKs. Presenting a talking-therapy 
for the CMHC with a high B_RISK might have made the affective view about 
using the talking-therapy less favourable, in turn, leading to a decrease in the 
perceived effectiveness of the talking-therapy. By contrast, presenting a 
talking-therapy for a CMHC with a low B_RISK might have made affective view 
about using the talking-therapy more favourable, in turn, leading to an increase 
in the perceived effectiveness of the talking-therapy. Unfortunately, affect 
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corresponding to each vignette was not measured in the current study and 
therefore it is not possible to explore this explanation further. Future studies 
should however consider measuring affect corresponding to the vignette. 
“Outcome bias” 
Another heuristic that may account for the underlying processes responsible for 
the impact of the B_RISK on perceptions of treatment effectiveness is the 
“outcome bias”. The “outcome bias” is a phenomenon whereby individuals 
judge health-care decisions by their ultimate outcome and not by the 
information that informed the decision known at the time the decision was 
made (Baron and Hershey 1988). In one of their experiments, an imaginary 
surgeon had to decide whether or not to perform a risky operation and 
participants were informed about the probabilities of success for each option. 
Participants were then told about the outcome of the operation and asked to 
judge the quality of the surgeon’s decision. The findings showed that 
participants were more likely to rate the quality of the surgeon’s decision as 
poor when the outcome of the operation had been bad. In other words, 
participants incorporated information that was unknown at the time the 
imaginary surgeon made the decision. They were thus holding the surgeon 
responsible for events beyond his/her control. 
The current findings may reflect a similar process whereby participants make 
their decision about the effectiveness of talking-therapy dependent on the 
overall likelihood of a good outcome. Other things being equal, this is invariably 
greater if the B_RISK is low. However, if this accounts for the processes 
underlying the impact of the B_RISK, it suggests a thinking error that is related 
to people’s understanding of numeracy. In turn, this would suggest that the 
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impact of the B_RISK might be moderated by numeracy. However, this was not 
detected in the current study. Alternatively, the findings documented under the 
“outcome bias” may themselves be explained through the “affect heuristic”, 
although no research was found to examine this possibility. 
“Availability heuristic” 
Rather than being based on the “affect heuristic”, the “outcome bias” may also 
be a result of the “availability heuristic”. The “availability heuristic” proposes 
that individuals base their decisions on information that is most available in 
memory (Tversky & Kahneman, 1974). For example, individuals tend to 
overestimate the chance of dying from plane accidents and underestimate the 
chance of dying from car accidents because the former are more vivid, more 
unusual, and more emotionally charged. The “availability heuristic” may also 
account for process underlying the “outcome bias”. That is, participants’ 
responses are most influenced by the information provided to them last (i.e. 
whether surgery resulted in a good or bad outcome). 
The “availability heuristic” is consistent with the current findings if the 
information most available in memory for the current participants was the 
remaining risk in the treatment group. The risk remaining in the treatment group 
is determined by the B_RISK and the risk reduction by the treatment. 
Unfortunately, the current study was not designed to examine memory content 
to evaluate this possible explanation.  
It is possible that the “availability heuristic” has even a stronger impact on the 
judgement of treatment effectiveness outside of this lab-based experiment, that 
is, in the real world. Most individuals will not know the effectiveness of talking-
90 
 
therapy in terms of the ARR or the RRR, or any other measure. The most likely 
information available to individuals is the risk remaining following treatment, as 
they observed friends or family going through treatment. As approximately 50% 
of those who had talking-therapy will not be in remission following treatment, 
treatments for CMHCs may be judged as ineffective, because the large 
proportion of people coming out of treatment might be salient compared to 
other health conditions. Media in film and writing may contribute to this, often 
portraying mental illness as untreatable (Wahl, 1997). 
4.3 Hypothesis 2: ARR 
The study also showed that participants judged those talking-therapies as more 
effective that had a higher ARR. In other words, participants were sensitive to 
differences in the ARR and thus the risk reduction provided. There is a lot of 
research describing that people respond to changes to the ARR (Akl et al., 
2011; Harmsen et al., 2012). Furthermore, a review has looked specifically at 
how the format of presenting the ARR influences participants’ judgment of the 
effectiveness of the treatments (Covey, 2007). The review found that often 
studies present the ARR without the B_RISK. This way of presenting 
information about treatments is deemed to be less informative for participants, 
in that, for example, it makes it more difficult for the reader to comprehend what 
the information actually means (Gigerenzer et al., 2007; Stovring, Gyrd-
Hansen, Kristiansen, Nexoe, & Nielsen, 2008). In the current study the ARR 
was presented in conjunction with the B_RISK, thus ensuring that people were 
best able to comprehend the information. 
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When the ARR is presented alongside the B_RISK, responses to the ARR are 
potentially confounded by the B_RISK and the RRR, which can be extrapolated 
from the ARR and the B_RISK. To date, the only study that had previously 
documented the impact of the B_RISK on judgements of effectiveness while 
controlling for the ARR and the RRR and was conducted on cancer treatments, 
could not document that the responses to the ARR were independent of the 
B_RISK (Vogt et al., 2012). By contrast, the current study was designed to be 
able to avoid the possibility that the B_RISK could provide an alternative 
explanation for the impact of the ARR on treatment perceptions. The findings of 
the current study show, for the first time, that the ARR influences treatment 
perceptions independent of the B_RISK and the RRR. 
4.4. Hypothesis 3: RRR 
The findings also demonstrated that people were not sensitive to changes in 
the RRR. This findings is somewhat counterintuitive in light of the extensive 
literature accrediting the RRR more persuasiveness than the ARR (Akl et al., 
2011). How can this finding be explained? There are several possible 
explanations.  
First, many of the studies demonstrating the relative persuasiveness of the 
RRR are designed in a way so that participants are explicitly provided with the 
RRR. For example “Among those who take the pills, there will be a 33% 
reduced risk of heart disease during the next 10 years” (Carling et al., 2008). 
This way of presenting information may include reference to the B_RISK, but 
the B_RISK is often not provided (Covey, 2011)(e.g. Carling et al., 2008). Thus, 
participants in studies that have demonstrated the persuasiveness of the RRR 
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are often only looking at the impact of the explicitly reported RRR. By contrast, 
the RRR was not reported in the current study. Instead, participants could 
derive the RRR by looking at the proportional reduction of risk using the icon 
arrays that were provided. Had the RRR had been explicitly reported in the 
current study the impact of the RRR treatment perceptions might have been 
detectable. It has been shown that explicitly presenting the RRR leads to 
participants being more influenced by the size of the RRR (Gyrd-Hansen, 
Kristiansen, Nexøe, & Nielsen, 2003). The ARR was explicitly reported and an 
impact of the ARR was detected (see Hypothesis 2). The reason for not 
explicitly reporting the RRR was that communication guidelines recommend 
against this because it can make interventions seem more effective than they 
really are (Gigerenzer et al., 2007).  
Second, detecting a unique impact of the RRR relied on participants being 
influenced by a difference in the RRR of 22% (i.e. 22% = (50% - 17%) - (17% - 
6%); see Table 2.6). If the difference had been larger, for example 50%, than 
participants’ responses to the RRR may have been more likely detect.  
Third, the RRR has little or no influence on perceptions of treatment 
effectiveness. The size of the effect of the RRR, as provided by the interaction 
between the ARR and the B_RISK, was partial η2 = 0.01, yielding an observed 
power of 0.274. A significant difference would have been detected for this 
effect size at a power of 0.80 had the sample size been 779. This might 
suggest that the findings from studies detecting such an impact may have been 
confounded by the B_RISK. However, in many studies the RRR was detected 
in which the B_RISK was not presented. 
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In summary, the absence of evidence to support the hypothesis that the RRR 
influences participants’ perceptions of the effectiveness is likely to be due to a 
combination of not explicitly presenting the RRR, a too small difference in the 
RRR across the vignettes, and a lack of power. Thus, the design of the study 
rather than the RRR not influencing people’s perceptions of the effectiveness of 
talking-therapy is likely to account for the current results. 
4.4 Numeracy  
4.5.1 Hypothesis 1: B_RISK 
Numeracy was not found to moderate the impact of the B_RISK, as defined by 
a non-significant three-way interaction between the ARR, the RRR, and 
numeracy. This is consistent with previous research (i.e. Study 1 and Study 2) 
not detecting such a moderating impact (Vogt et al., 2012). In other words, the 
B_RISK seems to influence people’s perceptions of treatment effectiveness if 
they have worse or better numeracy. This suggests that this impact is 
independent of mathematical understanding, making it unlikely that presenting 
the information in a numerically more accessible way, if such a way could be 
found, would change the results. The findings are consistent with the literature 
reviewing commonly reported heuristics (e.g. “loss aversion”, “availability 
heuristic”), showing that these heuristic are often independent from cognitive 
ability (Stanovich & West, 2008).  
An alternative explanation is that the lacking three-way interaction is a result of 
lacking power to detect such a difference. The effect size of the non-significant 
three-way interaction between the ARR, the RRR, and numeracy was partial η2 
= 0.02, yielding an observed power of 0.36. A significant difference would have 
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been detected for this effect size at a power of 0.80 had the sample size been 
539. However, the results suggest that a moderating impact of numeracy on 
the impact of the B_RISK would be small.  
There was a main effect of numeracy when examining Hypothesis 1, 
suggesting that those who were least numerate were judging talking-therapies 
as more effective. The results are consistent with those obtained from previous 
research (Study 1, Vogt et al., 2012), which showed that numeracy had a main 
effect on perceptions of treatment effectiveness; showing that those with poorer 
numeracy judged treatments as more effective than those with better 
numeracy. Some research has also found that those with poorer numeracy are 
more likely to opt for treatment (Carling et al., 2008). However, the perceived 
effectiveness and opting for treatment are different concepts, with the later 
being dependent on a number of other factors, such as perceived side-effects. 
Other research did not find that those with less numeracy were more likely to 
judge medical treatments as more effectiveness (Lipkus, Peters, Kimmick, 
Liotcheva, & Marcom, 2010). Interestingly, those with good numeracy 
perceived the treatment as effective as those with poor numeracy. This finding 
may be due to a sampling error. 
4.5.2 Hypothesis 2: ARR 
There was no evidence that numeracy moderated the impact of the ARR on 
treatment perceptions, as indicated by the non-significant interaction between 
the RRR, the B_RISK, and numeracy (see Table 3.3). However, numeracy was 
found to moderate the main effect of the RRR and the main effect of the 
B_RISK. There are at least three explanations for these findings. 
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First, the means suggest that those with lower numeracy were less responsive 
to differences in the RRR and the B_RISK. However, this explanation neglects 
the fact that the main effects of the RRR and the B_RISK were confounded by 
the differences in the ARR. That is, the main effects detected for the RRR and 
the B_RISK are caused, at least in part, by differences in the ARR. 
Furthermore, the current study found no evidence that the independent impact 
of the B_RISK was moderated by numeracy (as discussed under 4.5.1), and 
also did not detect an independent effect of the RRR on treatment perceptions 
(as discussed under 4.4). 
Second, those with poor numeracy are responding less to differences in the 
ARR. The fact that the three-way interaction between the B_RISK, the RRR, 
and numeracy was not significant may be due to insufficient power to detect a 
significant effect. The effect size of the three-way interaction between the 
B_RISK, the RRR, and numeracy was partial η2 = 0.022, yielding an observed 
power of 0.375. A significant difference would have been detected for this 
effect size at a power of 0.80 had the sample size been 489. Three previous 
studies are consistent this explanation .One showed that individuals who were 
more numerate were more responsive to differences in the ARR, with no 
difference detected with regards to the B_RISK (see Study 1 Vogt et al., 2012). 
It has also been documented that perceptions of treatment effectiveness in 
those with less numeracy were less responsive to the ARR (Lipkus et al., 
2010). Another study found that those with more schooling (i.e. >10 years) 
were responsive to the size of the ARR, while those with less schooling (i.e. 
<10 years) were not (Gyrd-Hansen et al., 2003). The study also found that, the 
impact of the RRR on treatment perceptions was independent of education 
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(Gyrd-Hansen et al., 2003). While no impact of the education was detected in 
the current study, it may be a proxy for numeracy. Indeed, education was 
associated with numeracy in the current study. 
Third, those with poor numeracy are not sensitive to changes in the ARR and 
the RRR. The fact that no three-way interactions with numeracy were detected 
may be due to lacking power. However, no independent effect of the RRR was 
found on treatment perceptions (as discussed under 4.4), suggesting it is 
unlikely that the RRR had an important function in the current study. 
In summary, the evidence from the literature suggests that the impact of the 
ARR on treatment perceptions might be dependent on numeracy, but not that 
of the RRR or the B_RISK. Future research might further address the question 
of whether the ARR is moderated by numeracy with a sample. 
Why would individuals with lower numeracy pay less attention to the treatment 
effect? There are at least two explanations and possibly a combination of 
these. First, the information may be too complex to be meaningfully understood 
by individuals who have poor numeracy. Indeed, having lower numeracy is 
associated with reduced information processing skills relevant to medical 
decision making, individuals with low numeracy levels are less likely to recall 
risk information and comprehend risk information (Zikmund-Fisher, Smith, 
Ubel, & Fagerlin, 2007). When individuals are asked about the information 
about medical treatments presented using the ARR, the RRR, and the B_RISK 
those with lower numeracy are less accurate in their judgment of the 
effectiveness of the medical treatment (Schwartz et al., 1997). Thus, in the 
97 
 
current study those with lower numeracy did not detect the lower effectiveness, 
that those with higher numeracy detected. 
Second, the finding that participants did not respond to the size of the 
treatment effect may suggest that those who did not correctly answer 
numeracy questions did not actually read the information provided in the 
questionnaire. This may particularly apply to those who did not answer any 
numeracy question correctly. The numeracy questions that were used did 
require some understanding of chance and percentages but did not require 
participants to know complex mathematical concepts, such as algebra. As 
such, it is surprising that nearly a quarter of participants did not get any answer 
correct if they tried to do so. However, participants who failed to answer any 
questions correctly were not otherwise notable as outliers or provided 
implausible information. The hypothesis that all those who scored 0 on the 
numeracy measure did not read the questionnaire at all is therefore unlikely, 
although it may be true for some.  
It is likely therefore that a combination of not understanding the information in 
the vignettes and not exerting sufficient effort into completing the questionnaire 
may be responsible for the finding that those with lower numeracy skills were 
less sensitive to differences in the treatment effect. 
4.5 Mood 
Although it was expected that participants’ mood would have an impact on the 
judgements of effectiveness or moderate the impact of the B_RISK on 
judgements of effectiveness, no such relationships were detected. One would 
have predicted such relationships on the basis of a number of factors. For 
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example, as described earlier, the “affect heuristic” would postulate that 
participants with lower mood would have at least perceived all treatment as 
less effective than individuals with better mood (Finucane et al., 2000). 
It is possible that mood did not have the expected impact on perceptions in the 
current study because compared to the normal population, the sample was 
skewed towards people with lower mood, with 75.8% of participants reporting 
symptoms of anxiety and sadness that indicate a CMHC. Thus, a ceiling effect 
may have been encountered. 
It has been suggested that not all negative affect is equal, specifically showing 
that anxiety and sadness have different impacts on decision making 
(Raghunathan & Pham, 1999). This was investigated with regards to making 
decisions about the risks and benefits of gambling with money and with regards 
to making decisions about employment opportunities. The findings showed that 
sadness biases preferences toward high-risk/high-reward options, whereas 
anxiety biases preferences toward low-risk/low-reward options (Raghunathan & 
Pham, 1999). In the current study, a combined measure of sadness (PHQ-2) 
and anxiety (GAD-2) was used, namely the PHQ-4. Repeating the analysis by 
breaking up the combined PHQ-4 into sadness and anxiety produced virtually 
identical findings (results not reported in the results section but shown in 
Appendix 6). Thus, in the current study, even when considered separately, 
sadness and anxiety did not influence treatment perceptions and did not 




In two of the three ANCOVA’s (Table 3.2 and Table 3.4) it was found that men 
found talking-therapies more effective than woman and in one ANCOVA (Table 
3.3), woman were more sensitive to differences in the treatment effect, 
perceiving vignettes with lower effectiveness as less effective than men, while 
being no different in their judgment of vignettes with higher effectiveness. 
This finding is broadly consistent with a study of Irish Government employees 
in which men were found to have a higher intention to participate in counselling 
(Hyland, McLaughlin, et al., 2012). Similarly, a Dutch study found that men had 
a higher intention to seek professional help for a CMHC than women, although 
there were no significant differences in the attitude towards seeking help 
(Westerhof et al., 2008). Unfortunately, intention were not measured in the 
current study, which limits the comparison.  
There are also studies that show no differences in attitude or intention to seek 
help for mental health problems between men and women (e.g. Vogel et al., 
2005). However, it is generally assumed that women have a more positive 
attitude towards using talking-therapy, for example (Mackenzie et al., 2006, 
2004). There is also a large number of studies showing that women have a 
higher intention to seek help for psychological difficulties (Addis & Mahalik, 
2003; Leong & Zachar, 1999; Masuda, Suzumura, Beauchamp, Howells, & 
Clay, 2005; Rickwood & Braithwaite, 1994; Yeh, 2002). 
The findings of the current study are therefore somewhat inconsistent with the 
larger literature. It is possible that the inconsistent findings are caused by 
cultural differences. European men may have a more favourable attitude 
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towards mental health services than non European men. Of the two studies 
that detected a more positive intention to seek help for psychological difficulties 
in men, one was conducted in Ireland and the other in Holland. By contrast, 
those studies detecting a more negative attitude and a lower intention to seek 
help among men were conducted in the US, Australia, Taiwan, and Japan. It is 
possible that culturally, talking-therapy is more acceptable for men in Europe, 
which is thus reflected in the current findings. Alternatively, the sample in the 
current study may have been self-selecting, reflecting a more positive attitude 
towards talking-therapy as compared to the general population. After all, 
participants were recruited into the study by placing advertisements about 
talking-therapy. It is possible though that only men who had a very positive 
attitude responded to the advertisement. This may be reflected in the lower 
proportion of men that was recruited into the current study. 
It is also possible that the more positive beliefs about the effectiveness of 
talking-therapies among men was related to presenting information using icon-
arrays. Receiving and processing this information could have impacted on 
participants. By contrast, in the above mentioned studies participants were 
simply asked about talking-therapies without having to first process numerical 
information. It is possible that men appreciated such information more, 
translating into higher perceptions of effectiveness.  
4.7 Recommended decision making 
The recommended gold-standard for judging treatments is that the decision 
should be based exclusively on measures of risk difference (i.e. ARR, odds 
ratio, number needed to treat) (Baron, 1997; Fetherstonhaugh et al., 1997; 
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Gigerenzer et al., 2007). Among health professionals the NNT is sometimes 
preferred because it frames the number of individuals at risk saved as the 
number of people that need to be treated to see a benefit from the treatment in 
one person (Cook & Sackett, 1995). As the NNT is the mathematical inverse of 
the ARR (i.e. 1/ARR=NNT), a treatment that has an ARR of 50% then has a 
NNT of 2; meaning that two people need to be treated for one person to benefit 
from the treatment. The advantage of focussing on the actual number of lives 
saved is that it is mathematically independent of the size of the B_RISK. For an 
individual at risk, a NNT of 2 can be interpreted as reflecting that there is a one 
in two chance that he/she will benefit from the treatment. Alternatively, a NNT 
of 10 (i.e. ARR = 10%) can be interpreted as reflecting that there is a one in 10 
chance that a person will benefit from the treatment. Even though the person 
has a one in 10 chance of benefiting from the treatment, the person’s absolute 
chance of a good outcome following treatment may be much higher, for 
example 90%, if the B_RISK is low (i.e. 20%).  
The odds-ratio is another measure of treatment effectiveness. However, it is 
hard to interpret and thus not normally used to communicate the effectiveness 
of treatments (Deeks, Higgins, & Altman, 2008). However, the odds-ratio is 
commonly used in the analysis of randomised controlled trials of treatments for 
dichotomous outcomes, which are used to establish whether a treatment is 
better than standard care (Deeks et al., 2008). The odds-ratio is based on the 
frequencies of a 2 x 2 contingency table and is an index of the relationship 
between two inherently dichotomous variables (e.g. cured vs. uncured). 
Suppose a clinical trial for the effectiveness of a talking-therapy for depression 
had two conditions: a group that received talking-therapy and a group that 
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received care as usual, with 100 subjects each. The study reported that four 
subjects in the treatment condition were cured, whereas only two subjects in 
the control group were cured. These data are presented in a 2 x 2 contingency 
table (Table 4.1).  
Table 4.1: 2 x 2 odds-ratio for B_RISK = 98% and ARR = 2% 
 Cured  
 Yes No Total 
New talking-
therapy  
4 96 100 
Care as usual 2 98 100 
Total 6 194 200 
Note: cells are labelled a, b, c, d, clockwise starting in the top-left. 
The cells have been labelled a, b, c, d, reading from left to right, top to bottom. 
The odds-ratio is calculated as follows (Lipsey & Wilson, 2001): OR = ad/bc = 
4*98/96*2 = 2.0417. To establish whether this odds-ratio represents a 
statistically significant difference, the confidence interval (CI) can be calculated. 
For the present example the 95% CIs is 0.3654 to 11.4081 (Wilson, 2001), 
suggesting that the difference is not significant. The baseline risk in this 
example is 98%, the ARR is 2%, and the RRR is also 2%. 
To demonstrate that the odds-ratio is independent of the B_RISK, in the next 
example the B_RISK is decreased to 4% keeping the ARR at 2%; this changes 
the RRR to 50%. This changes the cells in the 2 x 2 table (Table 4.2) and the 





Table 4.2: 2 x 2 odds-ratio for B_RISK = 4% and ARR = 2% 
 Cured  
 Yes No Total 
New talking-
therapy  
98 2 100 
Care as usual 96 4 100 
Total 6 194 200 
Note: cells are labelled a, b, c, d, clockwise starting in the top-left. 
Despite the big change in the B_RISK, the result in terms of the odds-ratio 
remains the same. This example shows that the way in which the effectiveness 
of RCTs is calculated, by using the odds-ratio, depends on the actual 
difference that the treatment makes as compared to the control group, and not 
on the B_RISK or the RRR. 
Other measures of effectiveness, such as the RRR, are mathematically 
depended on the B_RISK (Gigerenzer et al., 2007; Schünemann et al., 2008). 
That is, they suggest different levels of effect size depending on the size of the 
B_RISK, particularly, suggesting high effect sizes for low B_RISKs, and vice-
versa. For this reason the RRR is often regarded as misleading (Fagerlin et al., 
2011; Gigerenzer et al., 2007; Hoffrage, Lindsey, Hertwig, & Gigerenzer, 2000) 
and should not be used in the absence of presenting the B_RISK 
(Schünemann et al., 2008).  
However, when comparing and combining studies across different risk groups 
as part of a meta-analysis, the RRR might still be useful. There has been a 
discussion about whether the actual treatment effect depends on the B_RISK 
of a population. Specifically, it has been argued that the same treatment may 
be more beneficial for people with a higher B_RISK, (i.e. more severe clinical 
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presentations / high risk groups) in terms of the ARR and less beneficial at a 
lower B_RISK in terms of the ARR (Weisberg, Hayden, & Pontes, 2009). When 
meta-analyses then combine data from low and high risk group, the mean 
value may then not be representative of those at low risk or those at high risk 
groups. By comparison, the RRR can be more stable across risk groups 
(Smeeth, Haines, & Ebrahim, 1999). A recommended approach for reviews is 
to present a variety of NNTs across a range of B_RISKs (Smeeth et al., 1999), 
as done in a review of oral anticoagulants to prevent stroke (Aguilar & Hart, 
2005). However, a recent analysis of a meta-analysis on the effect of 
antidepressants on suicidality in children, did not find that the treatment effect, 
in terms of the ARR, depended on the B_RISK (Proschan, Brittain, & Fay, 
2010).  
4.8 Evidence for treatments of mental health conditions 
Throughout the thesis reference was made to the natural rate of recovery in 
comparison to the effectiveness of talking-therapies, drawing upon data from 
either the Cochrane Collaboration or NICE guidelines (e.g. Bisson & Andrew, 
2007; NICE, 2011). However, the data may be a simplification of the true rate 
of natural recovery from mental health conditions, which may be higher than 
that described in this thesis. Studying the untreated course of mental health 
conditions relies on using information from a variety of sources, including 
longitudinal studies prior to the development of treatments, wait-list controlled 
trials, or observational studies. These designs make it difficult to control for 
confounding factors, such as severity, or patients who do not seek treatment, 
who often experience less economical downfall (Coryell et al., 1995). For 
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example, an observational study that followed individuals with a recurrent 
depressive episode who did not seek treatment, found that 85% were in 
remission one year later (Michael A. Posternak et al., 2006). The study also 
found that those who sought help had lower recovery rates, more similar to 
those in wait-list controlled trials (M. A. Posternak & Miller, 2001). A recent 
meta-analysis using observational studies and wait-list controlled trials 
detected a recovery rate of untreated depression at 53% after one year 
(Whiteford et al., 2013). There is also data from naturalistic samples comparing 
patients who used antidepressants versus those who did not, showing that who 
did not use antidepressants did better one year later (Goldberg, Privett, Ustun, 
Simon, & Linden, 1998) and some research which suggests that a subset of 
patients may experience paradoxical effects (e.g. worsening of depression) 
from antidepressants when these are used for long periods (Fava, 2003). In 
summary, although the benefit of talking-therapy is not questioned per-se, it 
seems that at least some individuals may not be worse off without treatment; 
although the problem remains that it is not known beforehand who would be 
better off without treatment. 
Also, questions have been asked about how evidence regarding effectiveness 
is established. First, this includes relying almost exclusively on the RCT for 
evaluating whether a treatment works with some suggesting the use of 
complementary effectiveness studies that allow for an evaluation of treatments 
that more closely resembles clinical practice (Blatt & Zuroff, 2005; Leichsenring 
& Leibing, 2007; Leichsenring, 2004). Specific issues include the reliance of 
RCTs on treatment manuals, including few co-morbidities, and the 
methodological inappropriateness of RCTs for long-term psychoanalytic 
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therapy. Second, it includes the relative neglect of the impact on functioning by 
focussing on symptoms, despite evidence that the correlation between 
symptoms and functioning is weak and often bidirectional (McKnight & 
Kashdan, 2009). 
4.9 Weaknesses 
The study had several weaknesses. First, the study does not allow firm 
conclusions about the relative strength of the B_RISK, the ARR, or the RRR. 
By selecting vignettes so that out of four vignettes, two vignettes were the 
same on one factor and two on another, the third factor varied across the four 
vignettes. It was this unrestrained variation that then allowed drawing 
inferences on whether this third unrestraint factor influenced perceptions about 
the effectiveness. As inferences were made on the basis of the size of the 
variation in the unrestraint factor, it was implicit that a larger variation in the 
unrestraint factor would lead to larger observable effect sizes. However, the 
variation could not be made of equal size across the three comparisons for 
mathematical reasons. For example, keeping the relation between the ARR 
and the RRR constant, the B_RISK varied by 40% (see Table 2.4). By 
comparison, keeping the relation between the B_RISK and the RRR constant, 
the ARR varied by 20% (see Table 2.5). Finally, keeping the relation between 
the ARR and the B_RISK constant, the RRR varied by 22% (see Table 2.6). 
Second, to evaluate each of the three hypotheses, responses to four vignettes 
were analysed.  In all, participants were asked to judge six vignettes. Some 
vignettes were thus used interchangeably for different analyses. The design 
was based on the approach successfully used to distinguish between absolute 
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and personal risk estimates (Mason, Prevost, & Sutton, 2008). The benefit of 
this approach is that it keeps participant effort at a minimum while maximising 
the use of the collected information. The alternative would have been to ask 
participants to judge 12 vignettes. The downside of using vignettes 
interchangeably is that it increases the risk of a confounding factor inherent in 
one of the vignettes to influence the results. However, it would not have been 
feasible for participants to judge 12 vignettes, as the risk of response fatigue 
was highly likely. It has been demonstrated that questions asked later in a long 
survey are often prone to more measurement error or misclassification 
(Egleston, Miller, & Meropol, 2011). It is also likely that extending the 
questionnaire and requiring 12 vignettes to be judged would have reduced 
response rates (Deutskens, Ruyter, Wetzels, & Oosterveld, 2004). 
Third, intention to use talking-therapy were not measured and only perceptions 
about the effectiveness were assessed for each vignette. The reason was that 
it would have doubled the number of responses that participants would have 
had to make with regards to each vignette. Not having measured the intention 
to use talking-therapy limits the conclusions that can be drawn with regards to 
how relevant the current findings are at predicting whether or not people will 
make use of talking-therapies. However, beliefs about the effectiveness have 
been shown to be predictive of both intention to use talking-therapy, as well as, 
using taking-therapy in a previous study (Stecker et al., 2010). Similarly, there 
is a large body of evidence showing that intention is a determinant of behaviour 
(Webb & Sheeran, 2006).  
Fourth, using colourful information for the icon-arrays may have affected 
individuals who are colour blind and thus introduced some measurement error. 
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The icon-arrays were displayed using the colours, green for those helped by 
talking therapy, blue for those recovering naturally, and red for those who do 
not recover. Studies use a variety of ways to display icon-arrays. Some use 
only black and white icons (Galesic et al., 2009), others used multicolour icons 
(Zikmund-Fisher et al., 2010). No evidence was identified in the literature that 
has evaluated the extent to which coloured or black/white icon-arrays influence 
decision making. However, using coloured icon-arrays, which in piloting of the 
current study were found to be easier to understand, may have limited the 
understanding of those that were colour blind. In the UK, colour blindness 
among woman is less than 0.5% and less than 10% in men (Swanson & 
Cohen, 2003). Given the demographic imbalance in the sample this meant that 
is likely that fewer than 2% of participants had some form of impairment in 
seeing colours, which may have impaired their responses. Unfortunately, no 
question was included to ask participants whether they had impaired vision. 
Future studies should include such a question.  
Fifth, the type of icon used may have limited accuracy. Previous research has 
shown that the type of icon used in icon-arrays does not impact on the 
processing of risk information (Stone, Yates, & Parker, 1997). However, recent 
information shows that using restroom icons (i.e. / ) results in better 
understanding of the risk information as compared to simpler icons, such as 
blocks or ovals, (Zikmund-Fisher et al., 2013). Therefore, the study may have 
become more sensitive to the changes in the B_RISK, the ARR, and the RRR, 
had restroom icons been used.  
109 
 
Sixth, the sample was collected entirely via the internet and may therefore not 
be entirely representative of the UK population. Using internet samples restricts 
the participants to those who have internet access. The pros and cons of using 
internet samples have been discussed elsewhere and even though internet-
based studies are restrictive, face-to-face approaches place different 
restrictions on samples, for example they are usually obtained from specific 
locations or groups (Wright, 2005). By contrast, the current study was able to 
recruit participants from the whole of the UK and also age groups across the 
lifespan. However, the sample included more women than men. In the analysis 
gender was controlled for as a confounding factor and it was not detected to 
moderate the independent effects of the B_RISK and the ARR. Therefore, even 
though gender did have an impact on judgements of effectiveness, gender did 
not affect the three hypotheses. The sample also included fewer individuals 
from non-white ethnic groups (~6%) than would be expected from the general 
population in the UK, where 12% are from non-white ethnic groups (Office for 
National Statistics, 2011). The proportion of non-white individuals currently 
accessing the IAPT services ranges between10% and 16%, thus closely 
resembling the ethnicities in the UK (Glover, Webb, & Evison, 2010). Because 
of the large imbalance 6% to 94%, ethnicity was not included as a confounding 
variable (Tabachnick & Fidell, 2001). 
Seventh, the circumstances under which the study attempted to investigate the 
factors that influence people’s decisions are not reflective of what individuals 
encounter in the “real world” as they consider to use a talking-therapy for a 
CMHC. Patients considering to undergo cancer or cardiovascular treatment will 
now more frequently be offered information provided about the effectiveness of 
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the respective treatments. This is done to allow patients to make an informed 
decision about the treatment they are choosing (Wishart et al., 2010). By 
contrast, information about the effectiveness of talking-therapy is not offered 
routinely in the NHS. Therefore, the information shown to participants in the 
current study is unlikely to be currently presented to patients deciding to use 
talking-therapy. Nevertheless, it is postulated here that the judgement of the 
effectiveness of talking-therapy will inadvertently include common sense 
estimates of the B_RISK. Similarly, the somewhat artificial circumstances 
created for this study might become a common reality should a case be made 
in the NHS that making an informed decision about having talking-therapy 
should also include being informed about how effective it is likely to be (BPS, 
2008, 2009).  
Eight, the study was not designed to allow a follow-up to be conducted with the 
participants. This could have provided information about the stability of the 
impact of the B_RISK but also allowed to link participants’ perceptions to future 
use of talking-therapy. Unfortunately, this was beyond the scope of this project. 
Nine, participants were asked to state whether they were receiving or had 
received treatment for a mental health problem. Unfortunately, we did not 
distinguish whether this treatment included talking-therapy, pharmacotherapy, 
or both. Future studies should consider this. 
Ten, of the 365 people who consented to the study, only 210 completed the 
items relating to the dependent variable. Those participants who completed the 
questionnaire may be different to those who did not, potentially introducing a 
bias. It is possible that they may be more favourable towards talking-therapy. 
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To explore this further, data that was collected but not included in the thesis is 
useful. The first page of the questionnaire measured constructs of the Theory 
of Planned Behaviour applied to the use of talking-therapy (see Appendix 4). Of 
the 365 that consented to the study, 348 completed questions about attitude 
the construct on the Theory of Planned Behaviour. When comparing those who 
completed the measure relating to the dependent variable (n = 202, mean = 
4.803, SD = 1.690), which were presented on the second page of the 
questionnaire, to those who did not (n = 145, mean = 4.583, SD = 1.814) on 
the attitude towards talking-therapy, no significant difference was detected 
(t(346) = 1.168, p = 0.244). Thus, those who completed the questions relating 
to the dependent variable were not more favourable towards talking-therapy 
than those who dropped out earlier. It is possible that participants differed on 
another variable. For example, those who did not complete the questionnaire 
may have had lower numeracy and were deterred by the complexity of the 
vignettes. Unfortunately, it is not possible to explore this because numeracy 
was measured as one of the last constructs in the questionnaire and thus only 
completed by 202 participants.  
4.10 Strengths 
This study also had several strengths. First, the current study is the first to 
show that individuals decide on the effectiveness of talking-therapies for 
CMHCs on the basis of the B_RISK of the CMHCs.  
Second, it is the first study to show an independent effect of the ARR when 




Third, the sample was large and heterogeneous on many accounts. 
Importantly, 75.8% of participants had a PHQ4 score of ≥ six. Therefore, the 
sample represented a group of individuals in which the majority presented with 
symptoms of anxiety and sadness that may warrant a diagnosis of a CMHC 
and thus represented candidates for talking-therapy. The findings are therefore 
not based on a student sample or a group of healthy adults. Indeed, 
evaluations from IAPT show that the sample is similar in terms of the case 
levels of individuals accessing IAPT, showing PHQ-9 scores beyond a level 
indicating a mood disorder in 72.5% of users and showing GAD-7 scores 
beyond a level indicating an anxiety disorder in 77.4% of users (Glover et al., 
2010). 
Fourth, criticisms about common heuristics include that evidence shows 
contradictory findings or their disappearance when natural frequency 
information rather than probabilistic information is used (Gigerenzer, 1991; 
Koehler, 1996). However, the information presented in the current study was 
specifically designed to present information in natural frequencies, so as to 
make it more likely that people could understand the information. 
4.11 Clinical implications 
The clinical implications of detecting that perceptions of the effectiveness of 
talking-therapies are influenced by the B_RISK are manifold.  
4.11.1 For treatment uptake  
Perceptions about the effectiveness are important determinants for the initial 
uptake of therapy (Stecker et al., 2010). Currently, patients are not provided 
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with information about the effectiveness of talking-therapy. Despite of this, their 
perceptions about the effectiveness may be influenced by the risk in the 
treatment group as individuals form their opinion about talking-therapy through 
hear-say or media outlets. Psychological services may thus start to present 
information about their effectiveness on printed leaflets or websites, to inform 
prospective patients about the benefit of treatment. Other services, such as 
stop smoking services, have adopted this approach (NHS-Smokefree, 2014). 
There are also risks of presenting information about the ARR and the B_RISK. 
It is possible that by informing patients and other individuals about the impact 
of treatment and the B_RISK on the overall recovery rates, that they respond 
discouraged about the impact of talking-therapies. While the current study 
shows that a higher B_RISK, negatively, and higher ARR, positively, influence 
perceptions about the effectiveness of talking-therapies, some participants may 
hold overoptimistic perceptions about talking-therapies. In other words, when 
individuals learn about the ARR of talking-therapies and the B_RISKs, some 
may perceive them as less effective than they had perceived them before 
receiving the information. However, there is evidence from the promotion of 
stop smoking services that presenting smokers with the ARR of stop smoking 
services and the B_RISK of continuing to smoke increased attendance rates 
(Matcham, McNally, & Vogt, 2013).  
4.11.2 For recovery rates 
Perceptions about the effectiveness are also important determinants for the 
success of treatment once patients have engaged with therapy (Schindler, 
Hiller, & Witthöft, 2013). Patients who attend talking-therapy differ in the extent 
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to which they believe talking-therapy will help them overcome depression 
(Schindler et al., 2013). Those with a negative perception are 1.4 times more 
likely to drop out compared to those with a more positive perception. Asking 
patients about their perceptions about whether therapy will help them is 
therefore a valuable part in the assessment. Given the current findings, the 
conversation exploring the patient’s perception should attend to the possibility 
that a negative perception is influenced by the B_RISK of CMHCs. If patients’ 
expectations of treatment can be raised, this is likely to translate into lower 
drop-out rates and in turn to better outcomes. 
It is important to keep a perspective about the actual clinical impact that beliefs 
about the effectiveness will have on the decision to use talking-therapy. 
Research about decisions for preventative treatments for heart disease showed 
that while important, the treatment effectiveness seems to have only a 
moderate influence on people’s decisions about whether or not to use 
preventive medication (Harmsen et al., 2012). Other factors, such as personal 
or familial experience of the disease might be more important. This has been 
described as the ‘single most important reason’ (Czerlinski, Gigerenzer, & 
Goldstein, 1999). If patients’ primary concerns are indeed not the effectiveness 
of a treatment, understanding their underlying reasons for decision-making is 
important, and the communication between patient and health professional 
should reflect this. Practitioners ought thus not focus solely on communicating 
effectiveness to their patients, but also on patient characteristics, including their 
values about seeking help, previous experiences of the individual patient 
(Gigerenzer et al., 2007), and intermediate therapy goals (Greenberger & 
Padesky, 1995). However, the treatment effectiveness may be something that 
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is amenable to change if a negative perception is at least partly influenced the 
by the B_RISK. 
4.11.3 For gaining consent 
Under professional guidelines, psychologists have to ensure that patients 
consent to the treatment, which requires patients to be informed about the 
likely outcomes of engaging in therapy, including its benefits. This is 
documented through the British Psychological Society’s Code of Ethics and 
Consent (BPS, 2009). In this, the informed consent standard reads: “(i) Ensure 
that clients, particularly children and vulnerable adults, are given ample 
opportunity to understand the nature, purpose, and anticipated consequences 
of any professional services or research participation, so that they may give 
informed consent to the extent that their capabilities allow.” Similarly, the British 
Psychological Society’s Generic Professional Practice Guidelines states under 
informed consent about psychological activities that “The psychologist should 
provide information about ... the benefits of this activity, either directly to the 
client in the case of assessment or intervention, or indirectly in the case of 
systemic intervention, or to potential theoretical advances in the case of 
research” (BPS, 2008) . Currently, the information provided to patients about 
the likely success of therapy relies on providing patients with the dichotomous 
information that an intervention is effective, or not, for a specific condition, 
following evidence-based guidelines (e.g. NICE, 2009, 2011b). It does not, 
usually, involve more detailed information about the effect size (e.g. odds-ratio, 
ARR or RRR) or the B_RISK. If the standards of consent were to be tightened, 
as seen in other health conditions (Wishart et al., 2010), the effect size would 
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have to be communicated. This would require clinicians to take care that 
patients correctly interpret the treatment effect, without being influenced by the 
B_RISK. 
4.11.4 For clinicians  
Being more aware of the impact of the B_RISK on perceptions of treatment 
effectiveness may also be useful for individuals in dealing with treatment 
failures. It is unrealistic to expect that offering someone treatment will result in 
clinical success, as more than 50% of patients, that is, 1 in 2 patients are 
unlikely to go into remission for any given CMHC given the current state of 
treatments. 
4.11.5 For referrers 
Knowledge of the impact of the B_RISK may also be useful when dealing with 
referrers to psychological services. Anecdotal evidence from team meetings 
suggests that there are big differences in the frequency of referrals from 
individual health professionals, even in the same roles and services. Evidence 
from previous research showed that even those with medical training are likely 
to be influenced by the B_RISK when they evaluate the effectiveness of 
medical treatments (Vogt et al., 2012). It may be that when services are 
discussed with potential refers, the benefit of the talking-therapies are 
discussed by raising awareness that the B_RISK impacts on the overall 
proportion of people that can be expected to be in remission in any given 
CMHC following referral. There is also evidence that communicating the 
effectiveness of treatments for conditions with a high B_RISK (i.e. stop 
smoking services) to GPs by comparing it to other medical treatments using the 
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NNT increased referrals to stop smoking services (Vogt, Hall, Hankins, & 
Marteau, 2009). Presumably this was because GPs had underestimated the 
treatment effect relative to other treatments, because of the high B_RISK 
inherent to stop smoking services. 
4.11.6 For commissioners  
Knowledge of the B_RISK may also help in dealing with commissioners for 
psychological services. Often the way in which the effectiveness of the talking-
therapies is described in reports only discusses the rate of recovery (Chan & 
Adams, 2014; Gyani, Shafran, Layard, & Clark, 2011). For example, in a report 
aimed at detailing how to improve recovery rates for IAPT services in the UK, 
the recovery rates for a depressive episode (40.3%), GAD (52.2%), PTSD 
(45.2%), OCD (42.7%), phobia (48.1%) are presented (Gyani et al., 2011). 
However, nowhere in the report is a reference made to what might have been 
expected had no treatment been offered, even though the rate of recovery is 
based in part on the B_RISK. In principle, it is therefore not at all possible to 
determine whether the IAPT services were effective or not. Presenting 
information about the effectiveness in this way might mean that commissioners 
respond adversely to the high B_RISK. Public health decisions have been 
reported to be affected by this kind of reasoning, as described by the reduced 
willingness to pay for interventions that reflected a “drop-in-the-bucket” 
(Fetherstonhaugh et al., 1997). 
4.12 Future research 
The research identified several avenues for further research, some of which 
are highlighted here. First, the role of affect as the underlying process for the 
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impact of the B_RISK should be explored. Second, does presenting information 
about the treatment effect of talking-therapy, with and without the B_RISK, 
increase perceptions of treatment effectiveness? Third, to identify tools to 
communicate the treatment effect of talking-therapy that avoid a negative 
influence of the B_RISK, possibly by comparing the treatment effect to that of 
other common treatments. There are also a number of issues that future 
research should pay attention to, including the use of restroom icons, 
controlling for colour blindness, and measuring intention to use talking-therapy. 
Services may also want to consider including a measure of the perceived 
outcome of therapy as part of routinely collected information when patient 
commence treatment, to be better able to explore this potential barrier.    
4.13 Conclusion 
Participants consider the B_RISK of the condition when they judge the 
effectiveness of a talking-therapy. The results also showed that participants 
consider the ARR of a talking-therapy when they judge the effectiveness of a 
talking-therapy. Finally, the results showed that the RRR did not seem to 
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post traumatic stress disorder 
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treatment depression 
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anxiety depression treatment 
postpartum depression treatment 
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dealing with depression and anxiety 
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treatment for depression and anxiety 
treating anxiety attacks 
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cure anxiety attacks 
dealing with anxiety attacks 
ocd symptoms 
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cure for anxiety attacks 
low mood 
treatment for anxiety and depression 
how to control anxiety attacks 
best treatment for depression 
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1 1 v70plus5 
2 v90plus5 




 Value Label N 
Numeracy .00  50 
1.00  71 
2.00  51 
3.00  29 
MEDIAN(PHQ4,ALL) 
(Binned) 
1 1 45 
2 2 156 
MEDIAN(gender,ALL) 1.0  51 
2.0  150 
 

































12.768 1 12.768 .048 .828 .000 .048 .055 
RRR * ctreatment_1 Linea
r 
 
136.170 1 136.170 .507 .477 .003 .507 .109 
RRR * ptreatment_1 Linea
r 
 
13.028 1 13.028 .049 .826 .000 .049 .056 
163 
 
RRR * gender_1 Linea
r 
 
497.098 1 497.098 1.851 .175 .010 1.851 .273 
RRR * age_1 Linea
r 
 
461.307 1 461.307 1.718 .192 .009 1.718 .256 
RRR * edu_1 Linea
r 
 




51298.745 191 268.580 

















100.920 1 100.920 .370 .544 .002 .370 .093 




123.542 1 123.542 .452 .502 .002 .452 .103 




33.033 1 33.033 .121 .728 .001 .121 .064 




32.560 1 32.560 .119 .730 .001 .119 .064 




16.281 1 16.281 .060 .807 .000 .060 .057 









52148.934 191 273.031 
     




1246.270 1 1246.270 5.292 .023 .027 5.292 .629 






977.494 3 325.831 1.384 .249 .021 4.151 .364 






19.318 1 19.318 .082 .775 .000 .082 .059 






.014 1 .014 .000 .994 .000 .000 .050 






18.865 1 18.865 .080 .777 .000 .080 .059 






56.067 1 56.067 .238 .626 .001 .238 .077 




13.453 1 13.453 .057 .811 .000 .057 .057 











44980.767 191 235.501 
     
 
Levene's Test of Equality of Error Variances
a
 
 F df1 df2 Sig. 
30-5 (70 plus 5) .957 14 186 .499 
10-5 (90 plus 5) 1.560 14 186 .094 
90-15 (10 plus 15) 1.058 14 186 .399 
30-15 (70 plus 15) 1.417 14 186 .149 
 




Type I Sum 
of Squares df 
Mean 













706.848 .000 .787 706.848 1.000 
NumeracySc
ale 
23299.396 3 7766.465 2.923 .035 .044 8.769 .689 
PHQ4_1_L_
H 
1764.397 1 1764.397 .664 .416 .003 .664 .128 
ctreatment_1 2052.610 1 2052.610 .773 .381 .004 .773 .141 
ptreatment_1 1670.450 1 1670.450 .629 .429 .003 .629 .124 
gender_1 10951.730 1 10951.730 4.122 .044 .021 4.122 .524 
age_1 885.981 1 885.981 .333 .564 .002 .333 .089 
edu_1 9074.837 1 9074.837 3.415 .066 .018 3.415 .452 
Error 507498.181 191 2657.059      
 
Estimated Marginal Means 
 
1. Grand Mean 
Measure:MEASURE_1 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
51.385
a
 2.495 46.464 56.306 
 
2. RRR * ARR 
Measure:MEASURE_1 
RRR ARR Mean Std. Error 
95% Confidence Interval 





 2.869 42.349 53.667 
2 49.421
a
 2.986 43.532 55.310 
2 1 51.397
a
 2.713 46.045 56.748 
2 56.714
a






RRR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 48.714
a
 2.733 43.323 54.106 
2 54.055
a




(I) RRR (J) RRR 
Mean 
Difference (I-J) Std. Error Sig.
a
 




Lower Bound Upper Bound 
1 2 -5.341
*
 1.586 .001 -8.470 -2.211 
2 1 5.341
*




















































ARR Mean Std. Error 
95% Confidence Interval 





 2.537 44.698 54.707 
2 53.067
a




(I) ARR (J) ARR 
Mean 
Difference (I-J) Std. Error Sig.
a
 




Lower Bound Upper Bound 
1 2 -3.365
*
 1.600 .037 -6.520 -.210 
2 1 3.365
*
















































Numeracy Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
.00 58.666
a
 4.312 50.160 67.171 
1.00 46.853
a
 3.670 39.615 54.091 
2.00 54.191
a
 3.883 46.532 61.850 
3.00 45.830
a





















.00 1.00 11.813* 4.880 .016 2.187 21.439 
2.00 4.475 5.523 .419 -6.419 15.368 
3.00 12.836* 6.417 .047 .179 25.493 
1.00 .00 -11.813* 4.880 .016 -21.439 -2.187 
2.00 -7.338 4.930 .138 -17.063 2.387 
3.00 1.023 5.884 .862 -10.583 12.629 
2.00 .00 -4.475 5.523 .419 -15.368 6.419 
1.00 7.338 4.930 .138 -2.387 17.063 
3.00 8.361 6.108 .173 -3.686 20.409 
3.00 .00 -12.836* 6.417 .047 -25.493 -.179 
1.00 -1.023 5.884 .862 -12.629 10.583 





























MEDIAN(gender,ALL) Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1.0 54.863
a
 3.958 47.056 62.670 
2.0 47.907
a

























1.0 2.0 6.956 4.469 .121 -1.858 15.770 


































1 1 v10plus15 
2 v70plus5 




 Value Label N 
Numeracy .00  50 
1.00  71 
2.00  51 
3.00  29 
MEDIAN(PHQ4,ALL) 
(Binned) 
1 1 45 
2 2 156 
MEDIAN(gender,ALL) 1.0  51 
2.0  150 
 





















31732.091 1 31732.091 165.46
2 














285.497 1 285.497 1.489 .224 .008 1.489 .229 
RRR * ctreatment_1 Linea
r 
 
323.462 1 323.462 1.687 .196 .009 1.687 .253 
RRR * ptreatment_1 Linea
r 
 
300.642 1 300.642 1.568 .212 .008 1.568 .238 
RRR * gender_1 Linea
r 
 
1690.627 1 1690.627 8.816 .003 .044 8.816 .840 
RRR * age_1 Linea
r 
 
3.831 1 3.831 .020 .888 .000 .020 .052 
RRR * edu_1 Linea
r 
 




36629.695 191 191.779 

















126.472 1 126.472 .295 .588 .002 .295 .084 




839.954 1 839.954 1.958 .163 .010 1.958 .286 




253.925 1 253.925 .592 .443 .003 .592 .119 




779.711 1 779.711 1.818 .179 .009 1.818 .269 




5.403 1 5.403 .013 .911 .000 .013 .051 









81918.148 191 428.891 
     




2561.225 1 2561.225 15.737 .000 .076 15.737 .977 






697.420 3 232.473 1.428 .236 .022 4.285 .375 






10.743 1 10.743 .066 .798 .000 .066 .058 






303.834 1 303.834 1.867 .173 .010 1.867 .275 






63.714 1 63.714 .391 .532 .002 .391 .095 
170 
 






172.013 1 172.013 1.057 .305 .006 1.057 .176 




239.807 1 239.807 1.473 .226 .008 1.473 .227 









31085.327 191 162.750 
     
 




Type I Sum 
of Squares df 
Mean 













966.823 .000 .835 966.823 1.000 
NumeracySc
ale 
15619.885 3 5206.628 2.207 .089 .034 6.620 .554 
PHQ4_1_L_
H 
2386.859 1 2386.859 1.012 .316 .005 1.012 .170 
ctreatment_1 262.626 1 262.626 .111 .739 .001 .111 .063 
ptreatment_1 857.291 1 857.291 .363 .547 .002 .363 .092 
gender_1 4794.098 1 4794.098 2.032 .156 .011 2.032 .294 
age_1 1278.619 1 1278.619 .542 .463 .003 .542 .113 
edu_1 4565.101 1 4565.101 1.935 .166 .010 1.935 .283 
Error 450635.342 191 2359.347      
 
Estimated Marginal Means 
 
1. Grand Mean 
Measure:MEASURE_1 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
55.838
a
 2.351 51.201 60.476 
 
2. CGO * RRR 
Measure:MEASURE_1 
CGO RRR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1 51.397
a
 2.713 46.045 56.748 
2 67.235
a





 2.869 42.349 53.667 
2 56.714
a
 2.770 51.249 62.178 
 
3. Numeracy * RRR 
Measure:MEASURE_1 
Numeracy RRR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
.00 1 57.349
a
 4.385 48.699 65.999 
2 63.711
a
 4.059 55.705 71.716 
1.00 1 46.284
a
 3.732 38.922 53.645 
2 56.113
a
 3.454 49.300 62.926 
2.00 1 51.689
a
 3.949 43.899 59.478 
2 67.222
a
 3.655 60.013 74.432 
3.00 1 43.488
a
 5.155 33.320 53.656 
2 60.852
a
 4.771 51.441 70.262 
 
4. Numeracy * CGO 
Measure:MEASURE_1 
Numeracy CGO Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
.00 1 60.734
a
 4.209 52.431 69.037 
2 60.326
a
 4.616 51.222 69.430 
1.00 1 55.743
a
 3.582 48.677 62.809 
2 46.654
a
 3.928 38.906 54.402 
2.00 1 62.299
a
 3.791 54.822 69.776 
2 56.612
a
 4.156 48.413 64.810 
3.00 1 58.487
a
 4.948 48.727 68.248 
2 45.852
a
 5.426 35.150 56.554 
 
5. RRR * MEDIAN(gender,ALL) 
Measure:MEASURE_1 
RRR MEDIAN(gender,ALL) Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1.0 53.425
a
 4.025 45.485 61.364 
2.0 45.980
a
 2.646 40.761 51.199 
2 1.0 62.665
a
 3.725 55.317 70.013 
2.0 61.283
a











1 1 v10plus5 
2 v70plus5 




 Value Label N 
Numeracy .00  50 
1.00  71 
2.00  51 
3.00  29 
MEDIAN(PHQ4,ALL) 
(Binned) 
1 1 45 
2 2 156 
MEDIAN(gender,ALL) 1.0  51 
2.0  150 
 

































126.226 1 126.226 .777 .379 .004 .777 .142 
ARR * ctreatment_1 Linea
r 
 
80.063 1 80.063 .493 .483 .003 .493 .108 
ARR * ptreatment_1 Linea
r 
 
200.853 1 200.853 1.237 .268 .006 1.237 .198 
ARR * gender_1 Linea
r 
 
434.060 1 434.060 2.672 .104 .014 2.672 .370 
ARR * age_1 Linea
r 
 
188.789 1 188.789 1.162 .282 .006 1.162 .189 
173 
 
ARR * edu_1 Linea
r 
 




31022.923 191 162.424 

















10.671 1 10.671 .028 .867 .000 .028 .053 




6.777 1 6.777 .018 .893 .000 .018 .052 




38.680 1 38.680 .103 .749 .001 .103 .062 




36.315 1 36.315 .096 .757 .001 .096 .061 




16.566 1 16.566 .044 .834 .000 .044 .055 









71983.732 191 376.878 
     




273.583 1 273.583 1.858 .174 .010 1.858 .274 






470.088 3 156.696 1.064 .365 .016 3.193 .285 






5.683 1 5.683 .039 .844 .000 .039 .054 






70.452 1 70.452 .479 .490 .002 .479 .106 






23.188 1 23.188 .158 .692 .001 .158 .068 






51.376 1 51.376 .349 .555 .002 .349 .090 




13.712 1 13.712 .093 .761 .000 .093 .061 









28118.338 191 147.216 








Type I Sum 
of Squares df 
Mean 













685.652 .000 .782 685.652 1.000 
NumeracySc
ale 
20532.860 3 6844.287 2.580 .055 .039 7.739 .628 
PHQ4_1_L_
H 
1179.432 1 1179.432 .445 .506 .002 .445 .102 
ctreatment_1 1813.426 1 1813.426 .684 .409 .004 .684 .130 
ptreatment_1 2645.448 1 2645.448 .997 .319 .005 .997 .168 
gender_1 10647.952 1 10647.952 4.013 .047 .021 4.013 .513 
age_1 1406.509 1 1406.509 .530 .467 .003 .530 .112 
edu_1 9068.836 1 9068.836 3.418 .066 .018 3.418 .452 
Error 506730.793 191 2653.041      
 
Estimated Marginal Means 
 
1. Grand Mean 
Measure:MEASURE_1 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
50.209
a
 2.493 45.291 55.126 
 
2. ARR * CGO 
Measure:MEASURE_1 
ARR CGO Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1 44.717
a
 2.833 39.129 50.306 
2 48.008
a
 2.869 42.349 53.667 
2 1 51.397
a
 2.713 46.045 56.748 
2 56.714
a






MEDIAN(gender,ALL) Mean Std. Error 95% Confidence Interval 
175 
 
Lower Bound Upper Bound 
1.0 53.599
a
 3.955 45.798 61.400 
2.0 46.818
a

























1.0 2.0 6.781 4.465 .131 -2.027 15.588 




























Appendix 6: Alternative analysis with PHQ2 and GAD2 







1 1 v70plus5 
2 v90plus5 









MEDIAN(gender,ALL) 1.0 49 
2.0 137 
 



























609.260 3 203.087 .749 .525 .013 2.246 .208 
RRR * ctreatment_1 Linea
r 
 
120.614 1 120.614 .445 .506 .003 .445 .102 
RRR * ptreatment_1 Linea
r 
 
12.052 1 12.052 .044 .833 .000 .044 .055 
RRR * gender_1 Linea
r 
 
433.560 1 433.560 1.598 .208 .009 1.598 .242 
RRR * age_1 Linea
r 
 
455.879 1 455.879 1.680 .197 .010 1.680 .252 
177 
 
RRR * edu_1 Linea
r 
 
151.758 1 151.758 .559 .456 .003 .559 .115 
RRR * PHQ2 Linea
r 
 
11.574 1 11.574 .043 .837 .000 .043 .055 
RRR * GAD2 Linea
r 
 




47475.199 175 271.287 











594.646 3 198.215 .749 .524 .013 2.247 .208 




77.020 1 77.020 .291 .590 .002 .291 .084 




31.331 1 31.331 .118 .731 .001 .118 .064 




40.029 1 40.029 .151 .698 .001 .151 .067 




53.505 1 53.505 .202 .654 .001 .202 .073 




90.049 1 90.049 .340 .560 .002 .340 .089 




200.998 1 200.998 .759 .385 .004 .759 .139 









46320.076 175 264.686 
     




1170.012 1 1170.012 5.770 .017 .032 5.770 .666 






1232.017 3 410.672 2.025 .112 .034 6.075 .514 






14.606 1 14.606 .072 .789 .000 .072 .058 






299.276 1 299.276 1.476 .226 .008 1.476 .227 






89.091 1 89.091 .439 .508 .003 .439 .101 




64.756 1 64.756 .319 .573 .002 .319 .087 




5.753 1 5.753 .028 .866 .000 .028 .053 
178 
 




11.516 1 11.516 .057 .812 .000 .057 .056 









35487.714 175 202.787 
     
 




Type I Sum 
of Squares df 
Mean 













655.499 .000 .789 655.499 1.000 
NumeracySc
ale 
19603.108 3 6534.369 2.442 .066 .040 7.326 .601 
ctreatment_1 1301.472 1 1301.472 .486 .486 .003 .486 .107 
ptreatment_1 2018.471 1 2018.471 .754 .386 .004 .754 .139 
gender_1 9251.961 1 9251.961 3.458 .065 .019 3.458 .456 
age_1 167.031 1 167.031 .062 .803 .000 .062 .057 
edu_1 11196.364 1 11196.364 4.184 .042 .023 4.184 .530 
PHQ2 4243.202 1 4243.202 1.586 .210 .009 1.586 .240 
GAD2 1499.216 1 1499.216 .560 .455 .003 .560 .115 
Error 468283.664 175 2675.907      
 
Estimated Marginal Means 
 
1. Grand Mean 
Measure:MEASURE_1 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
50.271
a
 2.233 45.864 54.679 
 
2. RRR * ARR 
Measure:MEASURE_1 
RRR ARR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1 47.276
a
 2.539 42.264 52.287 
2 48.118
a
 2.662 42.865 53.372 
2 1 50.487
a
 2.428 45.695 55.279 
179 
 
2. RRR * ARR 
Measure:MEASURE_1 
RRR ARR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1 47.276
a
 2.539 42.264 52.287 
2 48.118
a
 2.662 42.865 53.372 
2 1 50.487
a
 2.428 45.695 55.279 
2 55.204
a






RRR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 47.697
a
 2.452 42.857 52.536 
2 52.846
a




(I) RRR (J) RRR 
Mean 
Difference (I-J) Std. Error Sig.
a
 




Lower Bound Upper Bound 
1 2 -5.149
*
 1.422 .000 -7.955 -2.342 
2 1 5.149
*






















































ARR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 48.881
a
 2.252 44.438 53.325 
2 51.661
a




(I) ARR (J) ARR 
Mean 
Difference (I-J) Std. Error Sig.
a
 




Lower Bound Upper Bound 
1 2 -2.780
*
 1.405 .049 -5.552 -.007 
2 1 2.780
*
















































Numeracy Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
.00 57.083
a
 4.442 48.317 65.849 
1.00 45.355
a
 3.408 38.629 52.081 
2.00 53.048
a
 3.954 45.244 60.852 
3.00 45.599
a





















.00 1.00 11.728* 5.093 .022 1.675 21.780 
2.00 4.034 5.854 .492 -7.519 15.588 
3.00 11.484 6.729 .090 -1.797 24.765 
1.00 .00 -11.728* 5.093 .022 -21.780 -1.675 
2.00 -7.693 5.141 .136 -17.839 2.453 
3.00 -.244 6.121 .968 -12.325 11.837 
2.00 .00 -4.034 5.854 .492 -15.588 7.519 
1.00 7.693 5.141 .136 -2.453 17.839 
3.00 7.450 6.402 .246 -5.186 20.085 
3.00 .00 -11.484 6.729 .090 -24.765 1.797 
1.00 .244 6.121 .968 -11.837 12.325 





























MEDIAN(gender,ALL) Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1.0 53.601
a
 3.874 45.956 61.246 
2.0 46.942
a
























1.0 2.0 6.659 4.661 .155 -2.539 15.858 























     
 







1 1 v10plus15 
2 v70plus5 









MEDIAN(gender,ALL) 1.0 49 
2.0 137 
 























27825.941 1 27825.941 149.54
1 






1801.453 3 600.484 3.227 .024 .052 9.681 .735 
RRR * ctreatment_1 Linea
r 
 
377.613 1 377.613 2.029 .156 .011 2.029 .294 
RRR * ptreatment_1 Linea
r 
 
157.688 1 157.688 .847 .359 .005 .847 .150 
RRR * gender_1 Linea
r 
 
1389.481 1 1389.481 7.467 .007 .041 7.467 .776 
RRR * age_1 Linea
r 
 
71.889 1 71.889 .386 .535 .002 .386 .095 
RRR * edu_1 Linea
r 
 
1018.998 1 1018.998 5.476 .020 .030 5.476 .643 
RRR * PHQ2 Linea
r 
 
310.221 1 310.221 1.667 .198 .009 1.667 .250 
RRR * GAD2 Linea
r 
 




32563.206 175 186.075 











2947.502 3 982.501 2.262 .083 .037 6.786 .564 




594.704 1 594.704 1.369 .244 .008 1.369 .214 




588.527 1 588.527 1.355 .246 .008 1.355 .212 




462.682 1 462.682 1.065 .303 .006 1.065 .177 




47.377 1 47.377 .109 .742 .001 .109 .062 




401.351 1 401.351 .924 .338 .005 .924 .159 




46.638 1 46.638 .107 .744 .001 .107 .062 









76015.870 175 434.376 
     




2174.710 1 2174.710 13.094 .000 .070 13.094 .949 
184 
 






680.324 3 226.775 1.365 .255 .023 4.096 .359 






296.733 1 296.733 1.787 .183 .010 1.787 .265 






12.169 1 12.169 .073 .787 .000 .073 .058 






102.551 1 102.551 .617 .433 .004 .617 .122 




407.526 1 407.526 2.454 .119 .014 2.454 .344 




102.280 1 102.280 .616 .434 .004 .616 .122 




.001 1 .001 .000 .998 .000 .000 .050 









29065.756 175 166.090 
     
 




Type I Sum 
of Squares df 
Mean 













908.274 .000 .838 908.274 1.000 
NumeracySc
ale 
13151.265 3 4383.755 1.883 .134 .031 5.649 .482 
ctreatment_1 61.898 1 61.898 .027 .871 .000 .027 .053 
ptreatment_1 1441.524 1 1441.524 .619 .432 .004 .619 .123 
gender_1 4256.030 1 4256.030 1.828 .178 .010 1.828 .270 
age_1 198.475 1 198.475 .085 .771 .000 .085 .060 
edu_1 6952.314 1 6952.314 2.986 .086 .017 2.986 .405 
PHQ2 4702.610 1 4702.610 2.020 .157 .011 2.020 .293 
GAD2 2027.149 1 2027.149 .871 .352 .005 .871 .153 
Error 407418.891 175 2328.108      
 
Estimated Marginal Means 
 




Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
54.597
a
 2.083 50.486 58.709 
 
2. CGO * RRR 
Measure:MEASURE_1 
CGO RRR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1 50.487
a
 2.428 45.695 55.279 
2 65.423
a
 2.202 61.077 69.769 
2 1 47.276
a
 2.539 42.264 52.287 
2 55.204
a
 2.456 50.357 60.051 
 







1 1 v10plus5 
2 v70plus5 









MEDIAN(gender,ALL) 1.0 49 
2.0 137 
 





























407.732 3 135.911 .852 .467 .014 2.555 .233 
ARR * ctreatment_1 Linea
r 
 
76.521 1 76.521 .480 .490 .003 .480 .106 
ARR * ptreatment_1 Linea
r 
 
273.286 1 273.286 1.713 .192 .010 1.713 .256 
ARR * gender_1 Linea
r 
 
321.595 1 321.595 2.015 .157 .011 2.015 .292 
ARR * age_1 Linea
r 
 
353.041 1 353.041 2.213 .139 .012 2.213 .316 
ARR * edu_1 Linea
r 
 
355.222 1 355.222 2.226 .137 .013 2.226 .317 
ARR * PHQ2 Linea
r 
 
95.279 1 95.279 .597 .441 .003 .597 .120 
ARR * GAD2 Linea
r 
 




27923.613 175 159.564 











1616.191 3 538.730 1.433 .235 .024 4.298 .375 




2.519 1 2.519 .007 .935 .000 .007 .051 




17.976 1 17.976 .048 .827 .000 .048 .055 




42.900 1 42.900 .114 .736 .001 .114 .063 




30.087 1 30.087 .080 .778 .000 .080 .059 




79.690 1 79.690 .212 .646 .001 .212 .074 




8.794 1 8.794 .023 .879 .000 .023 .053 









65810.704 175 376.061 
     




264.968 1 264.968 1.852 .175 .010 1.852 .273 
187 
 






337.026 3 112.342 .785 .504 .013 2.355 .217 






42.789 1 42.789 .299 .585 .002 .299 .085 






55.686 1 55.686 .389 .534 .002 .389 .095 






84.933 1 84.933 .594 .442 .003 .594 .119 




97.548 1 97.548 .682 .410 .004 .682 .130 




8.768 1 8.768 .061 .805 .000 .061 .057 




61.127 1 61.127 .427 .514 .002 .427 .100 









25041.381 175 143.094 
     
 




Type I Sum 
of Squares df 
Mean 













644.381 .000 .786 644.381 1.000 
NumeracySc
ale 
15783.002 3 5261.001 1.995 .117 .033 5.985 .507 
ctreatment_1 1145.223 1 1145.223 .434 .511 .002 .434 .100 
ptreatment_1 3362.508 1 3362.508 1.275 .260 .007 1.275 .202 
gender_1 8704.532 1 8704.532 3.301 .071 .019 3.301 .439 
age_1 239.816 1 239.816 .091 .763 .001 .091 .060 
edu_1 12620.549 1 12620.549 4.785 .030 .027 4.785 .585 
PHQ2 3455.192 1 3455.192 1.310 .254 .007 1.310 .207 
GAD2 846.599 1 846.599 .321 .572 .002 .321 .087 
Error 461526.702 175 2637.295      
 
Estimated Marginal Means 
 




Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
49.231
a
 2.217 44.856 53.607 
 
2. ARR * CGO 
Measure:MEASURE_1 
ARR CGO Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1 43.959
a
 2.520 38.986 48.932 
2 47.276
a
 2.539 42.264 52.287 
2 1 50.487
a
 2.428 45.695 55.279 
2 55.204
a






MEDIAN(gender,ALL) Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1.0 52.350
a
 3.846 44.760 59.940 
2.0 46.113
a
























1.0 2.0 6.236 4.627 .179 -2.896 15.368 






















     
 
